![]() |
![]() |
![]() |
![]() |
PV-0042 | Fractionated-TBI schedules prior to allograft: Study from the Acute Leukemia Working Party (EBMT) | Arefore Radiotherapy H Mondor | ![]() |
![]() |
|||
PV-0043 | Radiotherapy to the mediastinum in Hodgkins lymphoma: Is B-VMAT the only arc solution? | Catherine Hanna | ![]() |
![]() |
|||
PV-0044 | Is involved-node radiotherapy for Hodgkin lymphoma safe in routine? | Angela Boros | ![]() |
![]() |
|||
PV-0045 | Estimation of internal risk volume for coronary arteries after motion evaluation with ECG-gated CT | Mario Levis | ![]() |
![]() |
|||
PV-0046 | Comparison of respiratory-induced diaphragm motion during radiotherapy between children and adults | Sophie Huijskens | ![]() |
![]() |
|||
PV-0047 | Whole lung irradiation in patients with osteosarcoma and Ewing sarcoma: a systematic review | Gabriella Macchia | ![]() |
![]() |
|||
PV-0048 | Prognostic impact of tumor size and response in neoadjuvant radiotherapy of soft tissue sarcoma | Gabriella Macchia | ![]() |
![]() |
|||
PV-0050 | A Randomised controlled trial evaluating the utility of a patient Decision Aid to improve clinical trial (RAVES 08.03) related decision-making | Puma Sundaresan | ![]() |
![]() |
|||
PV-0087 | Improvement of models for survival prediction through inclusion of patient-reported symptoms | Carsten Nieder | ![]() |
![]() |
|||
PV-0088 | Half body irradiation schedule in patients with multiple bone metastases: a phase I-II trial | Gabriella Macchia | ![]() |
![]() |
|||
PV-0089 | Relation between pain control and bone mineral density change in bone metastases | Hidetoshi kobayashi | ![]() |
![]() |
|||
PV-0090 | The risk of myelopathy after reirradiation of the spinal cord. | Morten Hiul Suppli | ![]() |
![]() |
|||
PV-0091 | Quantifying the Gap Between Radiotherapy in the Elderly and the Demand for Age-Agnostic Treatment. | Thomas Mee | ![]() |
![]() |
|||
PV-0092 | Criterion-Based Benchmarking approach of the appropriate use of radiotherapy in NSW-ACT, Australia | Gabriel Gabriel | ![]() |
![]() |
|||
PV-0093 | Availability of radiotherapy in Africa: past and present of an unsolved problem | Eduardo Zubizarreta | ![]() |
![]() |
|||
PV-0131 | MR-only prostate external radiotherapy treatment planning - a multi-center/multi-vendor validation | Emilia Persson | ![]() |
![]() |
|||
PV-0132 | Comparison of planned versus simulated delivered dose in IMRT for endometrial cancer | Ingrid White | ![]() |
![]() |
|||
PV-0133 | Re-irradiation of pelvic recurrence of rectal cancer: Developing an adaptive plan ion strategy | Lars Nyvang | ![]() |
![]() |
|||
PV-0134 | Isotoxic stereotactic radiotherapy for central pelvic recurrence in gynecological cancer | Alexandra Taylor | ![]() |
![]() |
|||
PV-0137 | Validation of fast motion-including dose reconstruction for proton scanning therapy in the liver | Emma Colvill | ![]() |
![]() |
|||
PV-0138 | Pencil beam scanning treatments in free-breathing lung cancer patients is 5 mm motion a limit? | Annika Jakobi | ![]() |
![]() |
|||
PV-0183 | Microbrachytherapy: even more localised dose profiles? | Richard Brown | ![]() |
![]() |
|||
PV-0184 | Quantitative study on position margin in Intraluminal Brachytherapy Planning for lung treatment | CHI WAH KONG | ![]() |
![]() |
|||
PV-0185 | Retina dose as risk factor for worse visual outcome in 106Ru plaque brachytherapy of uveal melanoma | Gerd Heilemann | ![]() |
![]() |
|||
PV-0186 | MaxiCalc: a tool to calculate dose distributions from measured source positions in HDR brachytherapy | Maximilian Hanlon | ![]() |
![]() |
|||
PV-0187 | Source dwell time and transit time measurement for a HDR afterloading unit | Tin Lok Chiu | ![]() |
![]() |
|||
PV-0188 | Improved class solutions for prostate brachytherapy planning via evolutionary machine learning | Stefanus Maree | ![]() |
![]() |
|||
PV-0189 | Ring applicator source path determination using a high resolution ionisation chamber array | Mark Gainey | ![]() |
![]() |
|||
PV-0190 | The analysis of prostate cancer with median lobe hyperplasia treated I-125 brachytherapy | KOICHIRO MURAKI | ![]() |
![]() |
|||
PV-0233 | A Radiosensitivity Gene Signature & PD-L1 Predict Clinical Outcome of Breast Cancer in TCGA dataset | Bum-Sup Jang | ![]() |
![]() |
|||
PV-0234 | SPECT-CT visualization of axillary lymph nodes in breast cancer: the guide for radiotherapy planning | Sergey Novikov | ![]() |
![]() |
|||
PV-0235 | Is there a subset who benefits from PMRT in node-negative breast cancer patients? | HAE JIN PARK | ![]() |
![]() |
|||
PV-0236 | Impact of radiation therapy delay in patients underwent neoadjuvant chemotherapy and breast surgery | Gustavo Marta | ![]() |
![]() |
|||
PV-0237 | Management and outcome of local failure after intraoperative partial breast irradiation | Maria Cristina Leonardi | ![]() |
![]() |
|||
PV-0238 | Use of Stereotactic Ablative Radiotherapy in Non-Small Cell Lung Cancer Measuring 5 cm or More | Hill Tekatli | ![]() |
![]() |
|||
PV-0239 | Validation of lung cancer survival models in a clinical routine SBRT population | Johan van Soest | ![]() |
![]() |
|||
PV-0240 | A logistic regression model to predict 30-day mortality: difference between routine and trial data | Arthur Jochems | ![]() |
![]() |
|||
PV-0241 | Comparing endpoints of radiation induced lung injury for NSCLC: radiology vs. clinical symptoms | Uffe Bernchou | ![]() |
![]() |
|||
PV-0281 | Lymph node MRI in regional breast radiotherapy leads to smaller target volumes and lower OAR dose | Tristan van Heijst | ![]() |
![]() |
|||
PV-0282 | Out-of-plane motion correction in orthogonal cine-MRI registration | Matteo Seregni | ![]() |
![]() |
|||
PV-0283 | Gated liver SBRT based on internal electromagnetic motion monitoring | Esben Worm | ![]() |
![]() |
|||
PV-0284 | 3D Performance Analysis of Cyberknife Synchrony Respiratory Tracking System | Meryem Cansu Sahin | ![]() |
![]() |
|||
PV-0286 | Quantifying registration uncertainties in image-based data mining | Eliana M Vasquez Osorio | ![]() |
![]() |
|||
PV-0287 | Determination of MC-based predictive models for personalized and fast kV-CBCT organ dose estimation | Héléna Chesneau | ![]() |
![]() |
|||
PV-0320 | Stereotactic body radiotherapy (SBRT) for liver metastases based on functional treatment planning utilizing 218Ffluoro-2-deoxy-D-galactose PET/CT | Mette Marie Fode | ![]() |
![]() |
|||
PV-0321 | MRI guided stereotactic radiotherapy for locally advanced pancreatic cancer | Hanne Heerkens | ![]() |
![]() |
|||
PV-0322 | Rapid Early Response of Gastroesophageal Junction Tumors During Real-time MRI-Guided Radiotherapy | Hima Musunuru | ![]() |
![]() |
|||
PV-0323 | Development of a Prognostic Model incorporating PET Texture Analysis in Oesophageal Cancer Patients | Kieran Foley | ![]() |
![]() |
|||
PV-0324 | Dose to pelvic bone marrow defined with FDG-PET predicts for hematologic nadirs in anal cancer patients treated with concurrent chemo-radiation | Pierfrancesco Franco | ![]() |
![]() |
|||
PV-0325 | Tumor Regression Grading in the CAO/ARO/AIO-04 phase 3 trial in locally advanced rectal carcinoma | Emmanouil Fokas | ![]() |
![]() |
|||
PV-0326 | Time to surgery and pCR after neoadjuvant CRT in rectal cancer: a population study on 2113 patients | Gabriella Macchia | ![]() |
![]() |
|||
PV-0327 | The effect of postoperative complications on Quality of Life in elderly rectal cancer patients | Alice Couwenberg | ![]() |
![]() |
|||
PV-0328 | Factors associated with complete response after brachytherapy for rectal cancer; the HERBERT study. | Eva Rijkmans | ![]() |
![]() |
|||
PV-0369 | The potential of hyperpolarized C MRS to monitor the effect of vascular disrupting agents | Ane Iversen | ![]() |
![]() |
|||
PV-0371 | Novel molecular radiobiology for personalised prostate cancer radiotherapy | Laure Marignol | ![]() |
![]() |
|||
PV-0372 | Histology-specific quantitative mapping and targeting of glucose and glutamine metabolism in NSCLC | Tineke Meijer | ![]() |
![]() |
|||
PV-0373 | Glutamine metabolism as a potential target for prostate cancer radiosensitization | Anna Dubrovska | ![]() |
![]() |
|||
PV-0415 | Verification of pre-treatment DVH measurements for individual plan QA | Joep Stroom | ![]() |
![]() |
|||
PV-0416 | Novel methods for normal tissue dose in epidemiological studies of second cancer in radiotherapy | Choonsik Lee | ![]() |
![]() |
|||
PV-0417 | Validation of an analytical peripheral photon dose model for FFF modality | Mari Trini García-Hernández | ![]() |
![]() |
|||
PV-0418 | Characterisation of the prototype plastic scintillation detector (PSD) in a strong magnetic field | ASGHAR Gadhi | ![]() |
![]() |
|||
PV-0419 | The impact that geometric variability in ionization chamber construction has on kQQo | Josep Puxeu Vaqué | ![]() |
![]() |
|||
PV-0420 | Learn before you measure: Method of single-isolated errors analysis for ArcCheck. | Marta Gizynska | ![]() |
![]() |
|||
PV-0422 | Direct determination of kQ in a clinical carbon ion beam using water calorimetry | Julia-Maria Osinga-Blttermann | ![]() |
![]() |
|||
PV-0423 | AAPM TG-158 recommendations for neutron dosimetry for photon, electron, and light-ion therapy. | Rebecca Howell | ![]() |
![]() |
|||
PV-0456 | Volumetric Modulated Arc Therapy for patients with bilateral breast cancer | Sjors Lutjeboer | ![]() |
![]() |
|||
PV-0457 | Delay between planning and stereotactic radiotherapy for brain metastases: margins still accurate? | Veronique Vendrely | ![]() |
![]() |
|||
PV-0458 | FMECA of Cyberknife process: two years experience for improvement | Severine Cucchiaro | ![]() |
![]() |
|||
PV-0459 | Prostate CBCT dose optimization : from an iterative mAs reduction to a sytematic exposure reduction | enric jaegle | ![]() |
![]() |
|||
PV-0460 | Comparison of 3 Image-guided Adaptive Strategies for Bladder Radiotherapy | Vickie Kong | ![]() |
![]() |
|||
PV-0461 | Integrating diagnostic MRI in radical bladder cancer radiotherapy: Challenges in image registration. | Cynthia Eccles | ![]() |
![]() |
|||
PV-0462 | E-learning in the Radiotherapy Department- Ortello | Jocelyn de Jong | ![]() |
![]() |
|||
PV-0502 | Post-operative radiation therapy in atypical meningiomas: analysis of prognostic factors | SHAKIR SHAKIR | ![]() |
![]() |
|||
PV-0503 | Novel Recursive Partitioning Analysis Classification for Newly Diagnosed Glioblastoma: A Multi-institutional Study Highlighting the MGMT Promoter Methylation and IDH1 Gene Mutation Status | Chan Woo Wee | ![]() |
![]() |
|||
PV-0504 | Observed survival in 3270 patients treated with Whole Brain Radiotherapy compared to the QUARTZ data. Similar results for lung cancer (2.8 months) and breast cancer (3.8 months) | Paul Jeene | ![]() |
![]() |
|||
PV-0506 | Comparison of Clinical Behavior of Viral Related Oropharyngeal and Nasopharyngeal Carcinoma | Shao Hui Huang | ![]() |
![]() |
|||
PV-0508 | Prognostic significance of PD-L1 expression in patients with head and neck squamous cell carcinoma | Chuan Peng | ![]() |
![]() |
|||
PV-0509 | An interactive prognostic tool for ion of head-and-neck cancer patients for experimental treatments | Katrin Hkansson | ![]() |
![]() |
|||
PV-0510 | FMISO-PET/CT and functional MRI parameters as biomarkers during chemoradiation of HNSCC | Hatice Bunea | ![]() |
![]() |
|||
PV-0511 | Fitting NTCP models to patient reported xerostomia and dysphagia after H&N radiotherapy to 60Gy | Panayiotis Mavroidis | ![]() |
![]() |
|||
PV-0548 | The role of adjuvant therapy in stage IA serous and clear cell uterine cancer: a pooled analysis | Xuan Lu Qu | ![]() |
![]() |
|||
PV-0549 | National Cancer Data Base Analysis of SBRT, IMRT, and Brachytherapy Boost for Cervical Cancer | Michelle Ludwig | ![]() |
![]() |
|||
PV-0550 | Combined high dose radiation and tyrosine kinase inhibitors in renal cell carcinoma: a phase I trial | Nora Sundahl | ![]() |
![]() |
|||
PV-0551 | PSMA PET/CT vs MRI for GTV delineation in prostate cancer: a comparison with histology | Constantinos Zamboglou | ![]() |
![]() |
|||
PV-0552 | Urethra-sparing SBRT for prostate cancer: acute toxicity results from a randomized phase II trial | Thomas Zilli | ![]() |
![]() |
|||
PV-0553 | Prognostic significance of Testosterone Level in prostate carcinoma patients treated with TAB and RT | Gokhan Ozyigit | ![]() |
![]() |
|||
PO-0604 | A PET-based nomogram to predict survival in oropharyngeal cancers radiotherapy | castelli joel | ![]() |
![]() |
|||
PO-0605 | Factors associated with late dysphagia and xerostomia in (chemo)radiation for head and neck cancer. | Fréderic Duprez | ![]() |
![]() |
|||
PO-0606 | Mandible osteoradionecrosis in oropharynx carcinoma treated with IMRT | Francesca Caparrotti | ![]() |
![]() |
|||
PO-0608 | Depression, anxiety and claustrophobia in patients undergoing radiotherapy for head and neck cancer | Marie-Ève Pelland | ![]() |
![]() |
|||
PO-0609 | 18F-FDG-PET in Guiding Dose-painting with IMRT in Oropharyngeal Tumours (FiGaRO) Early Results | Andriana Michaelidou | ![]() |
![]() |
|||
PO-0611 | Long-term prognostic impacts of pretreatment plasma EBV DNA status in nasopharyngeal carcinoma | Jin-Ching Lin | ![]() |
![]() |
|||
PO-0612 | Significance of co-expression of mutant p53 protein and Ki67 in locally advanced HNSCC post chemo-RT | Priya Baskaran Shanmuga | ![]() |
![]() |
|||
PO-0614 | The prognostic role of 18F-FDG PET/CT in head and neck cancer and the importance of HPV status | Jon M. Moan | ![]() |
![]() |
|||
PO-0615 | Can diffusion-weighted MRI predict for xerostomia and QoL in head and neck patients receiving RT? | Kimberley Nguyen | ![]() |
![]() |
|||
PO-0616 | HPV, CSC marker expression and tumor hypoxia as prognosticators for LRC in patients with HNSCC | Linge Annett | ![]() |
![]() |
|||
PO-0618 | Role of PET in radiotherapy planning of head and neck tumors: a systematic review | Gabriella Macchia | ![]() |
![]() |
|||
PO-0619 | Comparison of a nanoString and RNA microarray gene signature predicting LRC after PORT-C in HNSCC | Stefan Schmidt | ![]() |
![]() |
|||
PO-0620 | Partial Laryngeal IMRT for T2N0 Glottic Cancer: Impact of Image Guidance and Radiotherapy Regimen | Kathy Rock | ![]() |
![]() |
|||
PO-0621 | Validation of tumor delineation on HE stained sections with cytokeratin staining as gold standard | Hans Ligtenberg | ![]() |
![]() |
|||
PO-0622 | Medulloblastoma in adults: a retrospective single institution analysis | Indrawati Hadi | ![]() |
![]() |
|||
PO-0623 | Impact of Interim Progression During the Surgery-to-Radiotherapy Interval and Its Predictors in Glioblastoma Treated with Radiochemotherapy | Chan Woo Wee | ![]() |
![]() |
|||
PO-0624 | Gammaknife Radiosurgery in patients receiving anticancer immunotherapy: efficacy and safety | Daniela greto | ![]() |
![]() |
|||
PO-0625 | Accelerated-hypofractionated IMRT plus Temozolomide in Glioblastoma:a phase I dose-escalation study | Gabriella Macchia | ![]() |
![]() |
|||
PO-0626 | Quality of life: result from a randomized trial that compared WBRT with radiosurgery of tumor cavity | Lucyna Kepka | ![]() |
![]() |
|||
PO-0627 | Prediction of radiosurgery response of brain metastases using convolutional neural networks | Mi-sook Kim | ![]() |
![]() |
|||
PO-0628 | Correlation between 18F-FDOPA uptake and tumor relapse in recurrent high-grade gliomas | isabelle chabert | ![]() |
![]() |
|||
PO-0630 | THE ROLE OF MC4R GENE POLYMORPHISMS IN GBM PATIENTS TREATED WITH CONCOMITANT RADIO-CHEMOTHERAPY. | Martina Cantarella | ![]() |
![]() |
|||
PO-0631 | Molecular subtypes of glioblastoma: immunohistochemical approach and clinical correlations | Luca Triggiani | ![]() |
![]() |
|||
PO-0632 | Phase I/II Trial on Intraoperative Radiotherapy (IORT) in Glioblastoma Multiforme (INTRAGO I/II) | Frank Anton Giordano | ![]() |
![]() |
|||
PO-0634 | Irradiation of Subventricular Zone in Glioblastoma: Its Impact on Tumor Progression and Survival | Fatma Sert | ![]() |
![]() |
|||
PO-0635 | Can psychological support during RT improve distress, mood or quality of life in CNS tumor patients? | Loredana Dinapoli | ![]() |
![]() |
|||
PO-0637 | HFSRT to the resection bed for intracranial metastases: a large retrospective study of 181 patients. | Audrey KELLER | ![]() |
![]() |
|||
PO-0638 | FET PET prior to primary RT of glioblastoma patients - a recurrence pattern analysis | Daniel Fleischmann | ![]() |
![]() |
|||
PO-0639 | Feasibility of tract based dosimetric analysis in brain tumor patients | Manuel Conson | ![]() |
![]() |
|||
PO-0640 | Which measurement type should be used for disease control of brain metastasis, volumetric or linear? | Gerrit Fischedick | ![]() |
![]() |
|||
PO-0641 | A novel voxel based homogeneity index: clinical implications for WBRT | Alexander Henry Thieme | ![]() |
![]() |
|||
PO-0643 | Scalp-sparing radiotherapy to minimize alopecia in patients with primary brain cancer | Silvia Scoccianti | ![]() |
![]() |
|||
PO-0644 | Overall survival following stereotactic radiosurgery (SRS) for breast cancer brain metastases | Hanisha Patel | ![]() |
![]() |
|||
PO-0646 | Nodular Lymphocyte Predominant Hodgkins Lymphoma (NLPHL): Early Outcomes | Nehal Khanna | ![]() |
![]() |
|||
PO-0647 | Factors associated with pulmonary toxicity after conditioning with total body irradiation | Hwa Kyung Byun | ![]() |
![]() |
|||
PO-0648 | Is age60 unfavorable prognostic factor in early stage upper aerodigestive tract NK/T-cell lymphoma? | Bo Chen | ![]() |
![]() |
|||
PO-0649 | Locoregional Treatment of the Primary Tumor Shows Survival Benefit in De Novo Stage IV Breast Cancer | Seo Hee Choi | ![]() |
![]() |
|||
PO-0650 | Omitting radiotherapy in triple-negative breast cancer leads to worse cancer-specific survival | Isabelle Kindts | ![]() |
![]() |
|||
PO-0651 | Five year outcome and soft tissue toxicity of breast cancer hypofractionated adjuvant radiotherapy | Andrei Fodor | ![]() |
![]() |
|||
PO-0652 | Risk factors for complications of post-mastectomy radiotherapy on implant-based reconstructed breast | Mami Ogita | ![]() |
![]() |
|||
PO-0653 | A heart atlas for breast RT and the influence of delineation education on observer variability | MELTEM KIRLI | ![]() |
![]() |
|||
PO-0655 | Patterns of locorégional failure in women with breast cancer treated by Postmastectomy Radiotherapy | youlia kirova | ![]() |
![]() |
|||
PO-0656 | Reirradiationhyperthermia after surgery for recurrent breast cancer: 70 5-year local control | Sabine Oldenborg | ![]() |
![]() |
|||
PO-0657 | Breast cancer subtypes and incidence/survival in patients with brain metastases | Yu Chen Tsai | ![]() |
![]() |
|||
PO-0658 | IMPACT OF BREAST RADIATION THERAPY ON COMPLICATIONS AFTER ALLOPLASTIC BREAST RECONSTRUCTION | Cristiane Chaves | ![]() |
![]() |
|||
PO-0659 | Hypofractionated-accelerated concomitant boost in moderate-high risk breast cancer:phase I-II study | Gabriella Macchia | ![]() |
![]() |
|||
PO-0660 | Partial breast re-irradiation with IMRT in patients with local failure after conservative treatment | Samantha Dicuonzo | ![]() |
![]() |
|||
PO-0661 | Intraoperative partial breast re-irradiation: a multicenter study of the AIRO IORT Working Group | Maria Cristina Leonardi | ![]() |
![]() |
|||
PO-0663 | Early toxicity of 150 patients treated with hypofractionated breast SIB-RT using advanced techniques | Akos Gulyban | ![]() |
![]() |
|||
PO-0664 | Standardized Nodal Radiation (RT) through a Breast Clinical Pathway (CP) within a USA Cancer Network | Brian Gebhardt | ![]() |
![]() |
|||
PO-0665 | The role of post-mastectomy radiotherapy (PMRT) and prognostic factors of locoregional recurrence | Durim Delishaj | ![]() |
![]() |
|||
PO-0666 | 30 Gy single-dose SBRT to lung lesions: outcome in a large series of patients | Luca Nicosia | ![]() |
![]() |
|||
PO-0667 | The differences between two groups of patients with NSCLC depending on the imaging for radiotherapy | Andrea Masarykova | ![]() |
![]() |
|||
PO-0668 | Five-fraction SBRT for central NSCLC in-field recurrences following high-dose conventional radiation | Michael Repka | ![]() |
![]() |
|||
PO-0669 | Models of pulmonary function changes after thoracic radiotherapy | Anne Niezink | ![]() |
![]() |
|||
PO-0670 | Administration of CPAP during lung cancer radiotherapy might allow for better sparing of normal lung tissue | Dario Di Perri | ![]() |
![]() |
|||
PO-0671 | Influence of radioresistant histologies on SBRT outcome for lung metastases | Davide Franceschini | ![]() |
![]() |
|||
PO-0672 | Delineation and eye-tracking: How to analyze treatment decisions according physician experience? | Florence Legouté | ![]() |
![]() |
|||
PO-0674 | SABR for lung tumors of 5cm or more: can knowledge-based planning detect high-risk treatment plans? | Saar van t Hof | ![]() |
![]() |
|||
PO-0675 | Evaluating commercial delineation software in routine clinical practice: analyzing time and quality. | Tim Lustberg | ![]() |
![]() |
|||
PO-0676 | OUTCOMES OF SYNCHRONOUS AND METACHRONOUS PULMONARY OLIGOMETASTASIS TREATED WITH SBRT | Aman Sharma | ![]() |
![]() |
|||
PO-0677 | Vero SBRT for early stage lung cancer: a phase II trial with dynamic tracking in ed lesions | Robbe Van den Begin | ![]() |
![]() |
|||
PO-0678 | Health-related quality of life reporting in lung cancer trials: A methodological appraisal. | Lotte Van der Weijst | ![]() |
![]() |
|||
PO-0680 | SBRT for locally advanced pancreatic cancer (LAPC): a retrospective multi-institutional experience | Gabriella Macchia | ![]() |
![]() |
|||
PO-0681 | SBRT VS standard chemoradiation in locally advanced pancreatic cancer (LAPC): a case-control study | Gabriella Macchia | ![]() |
![]() |
|||
PO-0682 | Re-irradiation for oligo-recurrence from esophageal cancer with radiotherapy history | Keiichi Jingu | ![]() |
![]() |
|||
PO-0684 | Opposite pharmacokinetics of sorafenib modulates by liver irradiation concurrent versus sequential | CHEN-HSI HSIEH | ![]() |
![]() |
|||
PO-0685 | The value of postoperative adjuvant therapy for pT2-3 esophageal cancer treated by radical resection | Zhu Shuchai | ![]() |
![]() |
|||
PO-0688 | Unresectable hepatic oligorecurrence SBRT of 55 lesion:Adequate dose coverage improves local control | Patrick Berkovic | ![]() |
![]() |
|||
PO-0689 | CLINICAL TARGET VOLUME IN BILIARY CARCINOMA: A SYSTEMATIC REVIEW OF PATHOLOGICAL STUDIES | Gabriella Macchia | ![]() |
![]() |
|||
PO-0690 | An initial result of carbon-ion radiotherapy for metastatic liver tumors. | Shingo Toyama | ![]() |
![]() |
|||
PO-0691 | Whole-body total lesion glycolysis is an independent predictor of thoracic esophageal cancer | Noriyoshi Takahashi | ![]() |
![]() |
|||
PO-0692 | The role of adjuvant chemoradiotherapy in patients with common bile duct cancer after R1 resection | Sang-Won Kim | ![]() |
![]() |
|||
PO-0693 | Stereotactic radiotherapy in hepatocellular carcinoma: a systematic review | Gabriella Macchia | ![]() |
![]() |
|||
PO-0694 | Post-operative Intensity-Modulated hypofractionated Image-Guided Radiotherapy in cholangiocarcinoma | Najla Slim | ![]() |
![]() |
|||
PO-0695 | Neo-adjuvant chemoradiotherapy and resection for esophageal cancer: outcomes in daily practice. | Edmée Portier | ![]() |
![]() |
|||
PO-0696 | A predictive nomogram for decision support for patients with pancreatic neuroendocrine tumors | Arthur Jochems | ![]() |
![]() |
|||
PO-0697 | Reduced inter- and intra-observer variation in esophageal tumor delineation using fiducial markers. | Melanie Machiels | ![]() |
![]() |
|||
PO-0698 | Phase II study of induction chemotherapy followed by radiochemotherapy in pancreatic cancer | Michele Fiore | ![]() |
![]() |
|||
PO-0699 | Is stereotactic radiotherapy following radiochemotherapy useful in local advanced pancreatic cancer? | Alessia Nardangeli | ![]() |
![]() |
|||
PO-0700 | Deep inspiration breath hold for radiotherapy of esophageal cancer reduces the heart dose significantly | Margriet Dieters | ![]() |
![]() |
|||
PO-0701 | Discrepancies between pathological data on nodal spread and the CTV used in adjuvant radiotherapy for biliary tract cancer | Joanna Socha | ![]() |
![]() |
|||
PO-0702 | Phase I trial evaluating panitumumab in combination with chemoradiotherapy for anal cancers | Veronique Vendrely | ![]() |
![]() |
|||
PO-0703 | Bowel dysfunction resulting from different treatment strategies in patients with rectal cancer. | Te Vuong | ![]() |
![]() |
|||
PO-0704 | Circulating angiogenesis factors predicting poor chemoradiotherapy outcome in rectal cancer | Sebastian Meltzer | ![]() |
![]() |
|||
PO-0705 | Patient-reported workability during the first year of rectal cancer treatment | Alice Couwenberg | ![]() |
![]() |
|||
PO-0706 | Assessing the impact of sentinel lymph-node and inguinal irradiation in patients with anal cancer | Calogero Gumina | ![]() |
![]() |
|||
PO-0707 | Magnetic Resonance Imaging Texture Analysis Parameters for predicting risk of Anal Cancer recurrence | Kasia Owczarczyk | ![]() |
![]() |
|||
PO-0708 | Patterns of Care in the Netherlands for Radiotherapy of Women with Locally Advanced Cervical Cancer | Peter de Boer | ![]() |
![]() |
|||
PO-0709 | Disease courses in women with residual tumor after concurrent chemoradiotherapy for cervical cancer | Young Seok Kim | ![]() |
![]() |
|||
PO-0711 | Risk factors for insufficiency fractures in cervix cancer following intensity modulated radiotherapy | Anne Ramlov | ![]() |
![]() |
|||
PO-0712 | Benefit of semi-extended field radiotherapy in patients with locally advanced cervical cancer | Jie Lee | ![]() |
![]() |
|||
PO-0713 | Diffusion-weighted MRI for predicting prognosis after radiotherapy in stage IIIB cervical cancer | Yui Watanabe | ![]() |
![]() |
|||
PO-0714 | Toxicity and Clinical Outcome of Intensity Modulated versus Conventional Whole Pelvic Radiation Therapy for Endometrial Cancer: A Prospective Randomized trial | Leila Vaalavirta | ![]() |
![]() |
|||
PO-0715 | A phase II study of chemoradiation with tri-weekly cycles of nedaplatin for uterine cervical cancer. | Kae Okuma | ![]() |
![]() |
|||
PO-0716 | Pelvic insufficiency fracture after IMRT for gynecologic or anal cancer | Louis Bazire | ![]() |
![]() |
|||
PO-0717 | Role of Radiation Therapy in Vulvar Cancer Patients with One or More Positive Inguinal Lymph Nodes | Margaux Kanis | ![]() |
![]() |
|||
PO-0718 | 18-FDG PET/CT parameters to predict survival and recurrence in cervical cancer | Nathaniel Scher | ![]() |
![]() |
|||
PO-0719 | The use of ultrasound bladder scanning in cervical IMRT to reduce variability of uterine motion | Sophie Otter | ![]() |
![]() |
|||
PO-0720 | CTV change during adaptive EBRT for cervix cancer: is mid-treatment plan adaptation required? | Dharman Dinesh Vignarajah | ![]() |
![]() |
|||
PO-0721 | Prediction of disease-free survival and locoregional control using pretreatment 18FDG PET/CT radiomics features in locally advanced cervical cancer treated with chemoradiotherapy | Franois Lucia | ![]() |
![]() |
|||
PO-0725 | Sigmoid colon is an important organ at risk for high-grade faecal urgency after pelvic radiotherapy | Rashmi Jadon | ![]() |
![]() |
|||
PO-0726 | Dose escalation with HDR brachytherapy for intermediate- and high-risk prostate cancer | Rodolfo Chicas-Sett | ![]() |
![]() |
|||
PO-0727 | Acute intestinal toxicity after whole-pelvis IMRT for prostate cancer from the patients perspective | Barbara Noris Chiorda | ![]() |
![]() |
|||
PO-0728 | BRCA2 mutation predicts poor survival in prostate cancer: A compelling evidence from 8,988 patients. | Ming Cui | ![]() |
![]() |
|||
PO-0729 | Normal Tissue Complication Probability for late urinary toxicities after RT for prostate cancer | Federica Palorini | ![]() |
![]() |
|||
PO-0730 | The independent benefit deriving from high doses and WPRT in salvage post-prostatectomy radiotherapy | Barbara Noris Chiorda | ![]() |
![]() |
|||
PO-0731 | Comparison of two fractionation schemes in prostate cancer patients treated with robotic SBRT | Gokhan Ozyigit | ![]() |
![]() |
|||
PO-0732 | Toxicity and outcome in moderately hypofractionated radiotherapy for 590 prostate cancer patients | andrea maucieri | ![]() |
![]() |
|||
PO-0733 | Radium 223: Difference in clinical outcomes between young and old | Yee Pei Song | ![]() |
![]() |
|||
PO-0734 | The effect of TAB duration and pelvic RT in prostate cancers with gleason score 8-10: TROG study | Gokhan Ozyigit | ![]() |
![]() |
|||
PO-0736 | Long term outcomes of IG-IMRT dose-escalation to pelvis and prostate for advanced prostate cancer | Hester Lieng | ![]() |
![]() |
|||
PO-0737 | ELECTIVE PELVIC RADIOTHERAPY IN CLINICALLY NODE-NEGATIVE PROSTATE CANCER: A LONG-TERM ANALYSIS | Anna Rita Alitto | ![]() |
![]() |
|||
PO-0738 | PET with 18F-Choline for evaluation of prostate cancer patients with biochemical relapse/persistence | Héctor Pérez-Montero | ![]() |
![]() |
|||
PO-0739 | Phase II Trial of Dynamic Dosimetry for prostate brachytherapy: correlation with post-implant MRI/CT | Daniel Song | ![]() |
![]() |
|||
PO-0740 | Surgery versus Radiotherapy in Uveal Melanoma: SEER Analysis using Propensity Score Matching & IPTW | Bum-Sup Jang | ![]() |
![]() |
|||
PO-0741 | IPILIMUMAB AND STEREOTACTIC RADIOSURGERY WITH CYBERKNIFE IN MELANOMA BRAIN METASTASES | Valentina Borzillo | ![]() |
![]() |
|||
PO-0742 | Target delineation conformity in extremity STS within the UK phase II multi-centre IMRiS trial | Huiqi Yang | ![]() |
![]() |
|||
PO-0743 | Retransplantation of bony autografts sterilized by extracorporal high dose irradiation | Ladan Saleh-Ebrahimi | ![]() |
![]() |
|||
PO-0744 | Brachytherapy and external beam radiation therapy after re-excision surgery in soft tissue sarcomas | Gabriella Macchia | ![]() |
![]() |
|||
PO-0745 | Intrafractional movement of patients with spinal cord compression receiving radiation therapy | Elin Ravnkilde | ![]() |
![]() |
|||
PO-0746 | Inter-observer variation in GTV delineation of bone metastases: a multicenter study | Joanne van der Velden | ![]() |
![]() |
|||
PO-0747 | Setting defaults in palliative radiation: a value-driven approach to improving care | Lindsay Puckett | ![]() |
![]() |
|||
PO-0748 | Efficacy of radiotherapy for painful bone metastases in elderly patients | Jon Cacicedo | ![]() |
![]() |
|||
PO-0749 | Early impact of pulmonary SBRT on Quality of Life: Benefit for patients with low initial QoL/GHS | Sonja Adebahr | ![]() |
![]() |
|||
PO-0750 | Failure to publish the results of clinical trials in oncology is skewing our medical practice | Pedro Franco | ![]() |
![]() |
|||
PO-0751 | Uptake of a novel interactive 3D web-based contouring atlas among the radiation oncology community | Erin Gillespie | ![]() |
![]() |
|||
PO-0752 | Birth Outcomes in Childbearing Age Female Cancer Survivors: A Nationwide Population-based Study | Wei-Heng Kao | ![]() |
![]() |
|||
PO-0754 | ISIORT pooled analysis 2016 update: clinical and technical characteristics of intraoperative radiotherapy in 11,025 patients | Marco Krengli | ![]() |
![]() |
|||
PO-0755 | Implementation of structural patient reported outcome registration in clinical practice | Iverna Nijsten - van Riesen | ![]() |
![]() |
|||
PO-0756 | Characterizing tissue equivalent materials used for an end-to-end QA phantom for MR-guided RT | Angela Steinmann | ![]() |
![]() |
|||
PO-0757 | Variation of mean dose output from 204 UK linacs (January-June 2015) and its potential clinical impact. | Matthew Bolt | ![]() |
![]() |
|||
PO-0758 | Development of patient-specific phantoms for verification of SBRT planning using 3D printer | Chae-Seon Hong | ![]() |
![]() |
|||
PO-0759 | Validation of the influence of M512 substrate resistivity on sensitivity degradation of radiation | Nauljun Stansook | ![]() |
![]() |
|||
PO-0760 | Investigation of PRESAGE formulation on signal quenching in a proton beam | Mitchell Carroll | ![]() |
![]() |
|||
PO-0761 | Dosimetry with Farmer ionization chambers in magnetic fields: Influence of the sensitive volume | C. Katharina Spindeldreier | ![]() |
![]() |
|||
PO-0762 | Real-time dosimetry with rare earth doped silica | Emiliano DAgostino | ![]() |
![]() |
|||
PO-0763 | Characterizing the response of Gafchromic EBT3 film in a 1.5 T magnetic field | Yvonne Roed | ![]() |
![]() |
|||
PO-0765 | Preparation and Fabrication of a Full-scale Patient-specific 3D-Printed Radiotherapy Phantom | Daniel Craft | ![]() |
![]() |
|||
PO-0766 | The effect of air gaps on Magic Plate (MP512) for small field dosimetry | kananan utitsarn | ![]() |
![]() |
|||
PO-0767 | Revisiting EPID design for modern radiotherapy requirements | Philip Vial | ![]() |
![]() |
|||
PO-0768 | Electron Paramagnetic Resonance signal from a new solid polymer material aimed for 3D dosimetry | María del Rocío Bernal Zamorano | ![]() |
![]() |
|||
PO-0769 | Suitability of microDiamond detectors for the determination of absorbed dose to water around high-dose-rate 192Ir brachytherapy sources | Vaiva Kaveckyte | ![]() |
![]() |
|||
PO-0772 | Real time error detection for VMAT: testing a novel transmission detector | Marlies Pasler | ![]() |
![]() |
|||
PO-0774 | Investigation of dose-rate dependence at an extensive range for PRESAGE radiochromic dosimeter | Evaggelos Pantelis | ![]() |
![]() |
|||
PO-0775 | Contributions to detector response in arbitrary photon fields | Sonja Wegener | ![]() |
![]() |
|||
PO-0776 | Thermoluminescence Characteristics of Fabricated Ge Doped Optical Fibre for Radiotherapy Dosimetry | Muhammad Safwan Ahmad Fadzil | ![]() |
![]() |
|||
PO-0777 | Importance of dosimetry formalism for cells irradiation on a SARRP and consequences for RBE | Morgane DOS SANTOS | ![]() |
![]() |
|||
PO-0778 | New Razor silicon diode for Cyber Knife small beam relative dosimetry: a multi-site evaluation | Serenella Russo | ![]() |
![]() |
|||
PO-0779 | New robotic phantom for evaluation of imaging and radiotherapy of moving structures | Henry Arenbeck | ![]() |
![]() |
|||
PO-0780 | Feasibility study of beam monitoring system using AFORS for proton pencil beam | Jaeman Son | ![]() |
![]() |
|||
PO-0781 | A characterisation of EBT3 Gafchromic film for relative and absolute dosimetry | Ilias Billas | ![]() |
![]() |
|||
PO-0782 | New liquid ionization chamber detector of high resolution for treatment verification in Radiotherapy | Luis Brualla Gonzalez | ![]() |
![]() |
|||
PO-0783 | Planverification in Robotic Stereotactic Radiotherapy with the Delta4-Dosimetry-System | Wolfgang Baus | ![]() |
![]() |
|||
PO-0784 | Volume correction factors for alanine dosimetry in small MV photon fields | Hans Lynggaard Riis | ![]() |
![]() |
|||
PO-0785 | A pencil beam algorithm for protons including magnetic fields effects | Fatima Padilla | ![]() |
![]() |
|||
PO-0786 | Energy dependence investigation for detectors used in out-of-field dosimetry | Laura Shields | ![]() |
![]() |
|||
PO-0787 | A compact and complete model for Bragg peak degradation in lung tissue | Riccardo Dal Bello | ![]() |
![]() |
|||
PO-0788 | First assessment of Delivery Analysis tool for pre-treatment verification on the new Radixact system | Andrea Girardi | ![]() |
![]() |
|||
PO-0789 | Demystifying failed VMAT PSQA measurements with ArcCHECK | Paul Kinsella | ![]() |
![]() |
|||
PO-0790 | In-vivo dosimetry for kV radiotherapy: clinical use of micro-silica bead TLD & Gafchromic EBT3 film | Antony Palmer | ![]() |
![]() |
|||
PO-0791 | Determination of water mean ionization potential for Geant4 simulations of therapeutical ion beams | Álvaro Perales Molina | ![]() |
![]() |
|||
PO-0792 | Monte-Carlo calculated energy deposition and nanodosimetric quantities around a gold nanoparticle | Tobias Dressel | ![]() |
![]() |
|||
PO-0793 | Absorbed dose distributions of ruthenium ophthalmic plaques measured in water with radiochromic film | Marcelino Hermida-López | ![]() |
![]() |
|||
PO-0794 | Comprehensive quality assurance test for high precision teletherapy | Sonja Wegener | ![]() |
![]() |
|||
PO-0795 | Comparison of Service graph log and Dynamic linac log of Elekta Linacs for patient QA. | Matthias Kowatsch | ![]() |
![]() |
|||
PO-0796 | Optimisation of plan robustness to sinus filling in a magnetic field. | Andrew Pollitt | ![]() |
![]() |
|||
PO-0797 | Studies on optical fiber dosimeters for in-vivo dosimetry in HDR brachytherapy | Luis Moutinho | ![]() |
![]() |
|||
PO-0798 | Identification of areas of high-risk skin toxicity in SBRT and IMRT treatments | Pablo Carrasco de Fez | ![]() |
![]() |
|||
PO-0800 | Log file based performance characterization of a PBS dose delivery system with dose re-computation | Till Tobias Bhlen | ![]() |
![]() |
|||
PO-0801 | Benchmarking Gate/Geant4 for oxygen ion beams | Andreas Resch | ![]() |
![]() |
|||
PO-0802 | Experimental validation of single detector proton radiography with scanning beams | Cezarina Chirvase | ![]() |
![]() |
|||
PO-0803 | CloudMC, a Cloud Computing application for fast Monte Carlo treatment verification | Hector Miras | ![]() |
![]() |
|||
PO-0804 | Relative dosimetry evaluation for small multileaf collimator fields on a TrueBeam linear accelerator | Tony Younes | ![]() |
![]() |
|||
PO-0805 | Commissioning of the new Monte Carlo algorithm SciMoCa for a VersaHD LINAC | Wolfgang Lechner | ![]() |
![]() |
|||
PO-0806 | Dosimetric end-to-end test procedures using alanine dosimetry in scanned proton beam therapy | Antonio Carlino | ![]() |
![]() |
|||
PO-0807 | Practical advantages of a transmission chamber in relative dosimetry of Brainlab conical applicators | Lucia Clara Orlandini | ![]() |
![]() |
|||
PO-0808 | Comparison of multi-institutional QA for VMAT of Nasopharynx with simulated delivery errors | David Thwaites | ![]() |
![]() |
|||
PO-0809 | A 3D polymer gel dosimeter coupled to a patient-specific anthropomorphic phantom for proton therapy | Guillaume Landry | ![]() |
![]() |
|||
PO-0810 | Absolute dose pre-treatment Portal Dosimetry using the Varian MAASTRO implementation | Ana Taborda | ![]() |
![]() |
|||
PO-0812 | Dosimetric impact of using Acuros algorithm for stereotactic lung and spine treatments | Laure Vieillevigne | ![]() |
![]() |
|||
PO-0813 | Break fewer hearts: Breath hold and protons for gentler lymphoma radiotherapy | Laura Rechner | ![]() |
![]() |
|||
PO-0814 | The Influence of scans parameters on effective dose of CBCT scans used for IGRT procedures | Abdullah Abuhaimed | ![]() |
![]() |
|||
PO-0815 | External neutron spectra measurements for a single room compact proton system | Rebecca Howell | ![]() |
![]() |
|||
PO-0816 | Towards a time-efficient treatment planning workflow for clinicians | Rens van Haveren | ![]() |
![]() |
|||
PO-0817 | Anatomical robust optimization to deal with variation in nasal cavity filling during IMPT | Steven van de Water | ![]() |
![]() |
|||
PO-0818 | Improving plan quality and efficiency by automated rectum VMAT treatment planning | Geert Wortel | ![]() |
![]() |
|||
PO-0819 | Robustness evaluation of single- and multifield optimized proton plans for unilateral head and neck | Macarena Cubillos Mesías | ![]() |
![]() |
|||
PO-0820 | Full automation of radiation therapy treatment planning | Laurence Court | ![]() |
![]() |
|||
PO-0821 | Automatic re-planning of VMAT plans in prostate and HN patients using constrained optimization | Luise Knzel | ![]() |
![]() |
|||
PO-0824 | IMRT dose painting for prostate cancer using PSMA-PET/CT: a planning study based on histology | Khodor Koubar | ![]() |
![]() |
|||
PO-0825 | Multi-scenario sampling in robust proton therapy treatment planning | Edmond Sterpin | ![]() |
![]() |
|||
PO-0826 | Evaluation of the new InCise MLC for Cyberknife stereotactic radiotherapy | Julien BELLEC | ![]() |
![]() |
|||
PO-0827 | Robustness Evaluation of Head and Neck Treatment with Proton Pencil Beam Scanning Technique | Haibo Lin | ![]() |
![]() |
|||
PO-0828 | Stereotactic body radiotherapy (SBRT) for localised prostate cancer on the MR-Linac | Angela Pathmanathan | ![]() |
![]() |
|||
PO-0829 | Robustness of IMRT and VMAT for interfraction motion in locoregional breast irradiation | Richard Canters | ![]() |
![]() |
|||
PO-0831 | Multi isocentric 4-pi volumetric modulated arc therapy approach for head and neck cancer | Shanmuga Subramanian | ![]() |
![]() |
|||
PO-0832 | The impact of variable RBE and breathing control in proton radiotherapy of breast cancer | Jakob dén | ![]() |
![]() |
|||
PO-0833 | Reducing small bowel dose for cervical cancer by combining proton therapy and target tailoring: a treatment planning comparison | Peter de Boer | ![]() |
![]() |
|||
PO-0834 | Automated planning to reduce integral dose in robotic radiosurgery for benign tumors | Linda Rossi | ![]() |
![]() |
|||
PO-0835 | PTV margin for pelvic lymph nodes in IGRT guided prostate radiotherapy | Henrik Jensen | ![]() |
![]() |
|||
PO-0837 | Dosimetric advantages afforded by Dynamic WaveArc therapy accelerated partial breast irradiation | Yuka Ono | ![]() |
![]() |
|||
PO-0838 | Treatment planning for the MR-linac: plan quality compared with current clinical practice | Stijn van de Schoot | ![]() |
![]() |
|||
PO-0839 | Personalized VMAT optimization for pancreatic SBRT | Ivaylo Mihaylov | ![]() |
![]() |
|||
PO-0840 | Hypofractionated intensity modulated radiotherapy in patients with immediate breast reconstruction | Damaris Patricia Rojas | ![]() |
![]() |
|||
PO-0841 | Feasibility of dose decrease in a rectal sub-region predictive of bleeding in prostate radiotherapy | Caroline Lafond | ![]() |
![]() |
|||
PO-0842 | A comparison of heart sparing techniques for breast and internal mammary chain radiotherapy | Alison Ranger | ![]() |
![]() |
|||
PO-0843 | volumetric-modulated Dynamic WaveArc therapy reduces the doses to the hippocampus | Megumi Uto | ![]() |
![]() |
|||
PO-0844 | Dosimetric Evaluation of MLC and Fixed Cone for Patients in the Prone Position with CyberKnife | Seung Kwon Ahn | ![]() |
![]() |
|||
PO-0846 | Bowel dose-volume relationship for patient-reported acute intestinal toxicity from pelvic IMRT | Carla Sini | ![]() |
![]() |
|||
PO-0847 | The dose-response curve of post-treatment FDG-uptake in lung tissue of irradiated NSCLC patients | Matthew La Fontaine | ![]() |
![]() |
|||
PO-0848 | Predictors of patient-reported incontinence after prostate cancer RT: results from a cohort study | Cesare Cozzarini | ![]() |
![]() |
|||
PO-0849 | Trismus after chemoradiation in head & neck cancer: relation with medial pterygoid and masseter dose | Olga Hamming-Vrieze | ![]() |
![]() |
|||
PO-0850 | Predicting late fecal incontinence risk after RT for prostate cancer:external independent validation | alessandro cicchetti | ![]() |
![]() |
|||
PO-0851 | Artificial neural networks for toxicity prediction in RT: a method to validate their intelligence | Mauro Carrara | ![]() |
![]() |
|||
PO-0852 | External validation of a TCP model predicting PSA relapse after post-prostatectomy Radiotherapy | Sara Broggi | ![]() |
![]() |
|||
PO-0853 | A method for automatic ion of parameters in NTCP modelling | Damianos Christophides | ![]() |
![]() |
|||
PO-0854 | Is radiation-induced trismus a time dependent masticatory structure story? | Maria Thor | ![]() |
![]() |
|||
PO-0855 | Use of the LKB model to fit urethral strictures for prostate patients treated with HDRB | Vanessa Panettieri | ![]() |
![]() |
|||
PO-0856 | Systematic baseline shifts of lymph node targets between setup and treatment of lung cancer patients | Mai Lykkegaard Schmidt | ![]() |
![]() |
|||
PO-0857 | Analysis of Intrafraction Motion in Image-Guided Stereotactic Radiosurgery of Spinal metastases | Jrund Graadal Svestad | ![]() |
![]() |
|||
PO-0859 | Impact of 4DCBCT reconstruction algorithm and surrogate on motion representation | Elisabeth Steiner | ![]() |
![]() |
|||
PO-0860 | Characterization of a novel liquid fiducial marker for organ motion monitoring in prostate SBRT | Robin De Roover | ![]() |
![]() |
|||
PO-0861 | Geometric validation of a 4D-MRI guided correction strategy on the MR-Linac | Tessa van de Lindt | ![]() |
![]() |
|||
PO-0862 | Correlation of Liver and Pancreas Tumor motion with Normal Anatomical Structures | Robert Kaderka | ![]() |
![]() |
|||
PO-0864 | Accuracy of fiducial based correction of target motion in prostate SBRT treatments | Tuomas Viren | ![]() |
![]() |
|||
PO-0865 | Commissioning and clinical implementation of intra-fractional 4D-CBCT imaging for lung SBRT | Richard Sims | ![]() |
![]() |
|||
PO-0866 | Visibility, image artifacts and proton dose perturbation of fiducial markers | Vincent Hamming | ![]() |
![]() |
|||
PO-0867 | Magnitude and robustness of motion mitigation in stereotactic body radiation therapy of the liver | Christian Heinz | ![]() |
![]() |
|||
PO-0870 | DIBH produces a meaningful reduction in lung dose for some women with right-sided breast cancer | Jessica Conway | ![]() |
![]() |
|||
PO-0871 | Study of the effect of heterogeneous setup random errors in treatment margins | David Sevillano | ![]() |
![]() |
|||
PO-0873 | Intra- and inter-fraction motion uncertainties during IGRT for Wilms tumour | Filipa Guerreiro | ![]() |
![]() |
|||
PO-0875 | Dosimetric effects of anatomical changes in proton therapy of head and neck (H&N) cancer | GLORIA MIORI | ![]() |
![]() |
|||
PO-0876 | Treatment adaptation is mandatory for intensity modulated proton therapy of advanced lung cancer | Lone Hoffmann | ![]() |
![]() |
|||
PO-0877 | Proton therapy of oesophageal cancer is more robust against anatomical changes than photons | Ditte Moeller | ![]() |
![]() |
|||
PO-0879 | Differences between planned and delivered maximum spinal cord dose in Head & Neck cancer patients | David Noble | ![]() |
![]() |
|||
PO-0880 | Using accumulated delivered dose to predict rectal toxicity in prostate radiotherapy | Leila Shelley | ![]() |
![]() |
|||
PO-0881 | 4DMRI for RT planning; novel precise amplitude binning in the presence of irregular breathing | Zdenko van Kesteren | ![]() |
![]() |
|||
PO-0882 | Proxy-free low-pitch helical 4DCT reconstruction | René Werner | ![]() |
![]() |
|||
PO-0884 | Availability of MRI improves interobserver variation in CT-based pancreatic tumor delineation | Oliver J. Gurney-Champion | ![]() |
![]() |
|||
PO-0885 | Assessment of Intratumoral Dose Response (SF2) Constructed Using Multiple FDG PET Images | Di Yan | ![]() |
![]() |
|||
PO-0888 | Response monitoring by 18FDG-PET in locally advanced NSCLC treated with concurrent chemoradiotherapy | Judi van Diessen | ![]() |
![]() |
|||
PO-0889 | FLT PET kinetic analysis biomarkers of resistance to radiotherapy for nasal tumours in canines | Urban Simoncic | ![]() |
![]() |
|||
PO-0890 | Image-based radiobiology: predicting the evolution of hypoxia during radiotherapy | Mireia Crispin Ortuzar | ![]() |
![]() |
|||
PO-0891 | Quality assessment of target volume delineation and dose planning in the Skagen Trial 1 | Giulio Francolini | ![]() |
![]() |
|||
PO-0892 | Automatic quality assurance of rectal contours on image guidance scans | Marina Romanchikova | ![]() |
![]() |
|||
PO-0893 | Improving CBCT image quality for daily image guidance of patients with head/neck and prostate cancer | Pascal Paysan | ![]() |
![]() |
|||
PO-0894 | Comparing the spatial integrity of 7T and 3T MR images for image-guided radiotherapy of brain tumors | Jurgen Peerlings | ![]() |
![]() |
|||
PO-0895 | MRI-based analysis of volumetric changes of healthy brain tissue in glioma patients after photon RT | Andreas Gommlich | ![]() |
![]() |
|||
PO-0896 | Quantitative MRI-based characterization of obturator muscles after prostate cancer radiotherapy | Elisa Scalco | ![]() |
![]() |
|||
PO-0897 | Atlas-based auto-segmentation of heart structures in breast cancer patients | Robert Kaderka | ![]() |
![]() |
|||
PO-0898 | Automated segmentation for breast cancer radiation therapy based on the ESTRO delineation guideline. | Ahmed Ramadan Eldesoky | ![]() |
![]() |
|||
PO-0900 | Quantifying the Effect of MRI Geometrical Distortions on Radiotherapy Treatment Planning Doses. | Mary Adjeiwaah | ![]() |
![]() |
|||
PO-0901 | Is MRI in immobilization mask necessary for brain metastasis patients? | Astrid van Lier | ![]() |
![]() |
|||
PO-0902 | Identifying the dominant prostate cancer focal lesion using 3D image texture analysis | William Nailon | ![]() |
![]() |
|||
PO-0903 | Patient-induced susceptibility effects simulation in magnetic resonance imaging | Mikael Bylund | ![]() |
![]() |
|||
PO-0904 | Development of an MRI-protocol for radiotherapy treatment guidance in gastric cancer | Vivian van Pelt | ![]() |
![]() |
|||
PO-0905 | (Semi-)Automatic contouring strategies for rectal boost treatment on the MR-Linac | Christel Nomden | ![]() |
![]() |
|||
PO-0906 | Textural analysis of MR images to improve the characterisation of recurrent prostate cancer | James Stirling | ![]() |
![]() |
|||
PO-0907 | Remote auditing of IMRT/VMAT deliveries | Narges Miri | ![]() |
![]() |
|||
PO-0908 | APPLICATION OF Failure and effects analysis to linac quality controls: advantages and limits | Francesca Bonfantini | ![]() |
![]() |
|||
PO-0909 | QA test of MLC speed using a fluorescent screen-CCD based dosimetry system | BIN YANG | ![]() |
![]() |
|||
PO-0910 | Is Linac-Based Total Body Irradiation (TBI) on the coach by VMAT Feasible? | BORA TAS | ![]() |
![]() |
|||
PO-0911 | Can the therapeutic benefits of microbeam radiation therapy be achieved using a clinical linac? | Natalka Suchowerska | ![]() |
![]() |
|||
PO-0912 | Short- and long term stability of the isocenter of a three-source Co60 MR guided radiotherapy device | Daan Hoffmans | ![]() |
![]() |
|||
PO-0913 | A national review of equipment, techniques and PTV margins used for SRS | Rushil Patel | ![]() |
![]() |
|||
PO-0915 | Performance study of a prototype straight-through linac delivery system with an EPID assembly | Ryan Scheuermann | ![]() |
![]() |
|||
PO-0916 | Feasibility and potential for treating locally advanced non-small cell lung cancer with a MR-linac | Hannah Bainbirdge | ![]() |
![]() |
|||
PO-0917 | Nationwide audit of small fields output calculations in Poland | Wojciech Bulski | ![]() |
![]() |
|||
PO-0918 | Radiotherapy and Her2 targeting agents: synergy in clonogenic and confluence assays | Natalka Suchowerska | ![]() |
![]() |
|||
PO-0919 | Stereotactic radiotherapy for brain metastases : Cyberknife versus VersaHD / ExacTrac | Mickael PERDRIEUX | ![]() |
![]() |
|||
PO-0920 | Utilizing monte carlo for log file-based delivery QA | Carl Stanhope | ![]() |
![]() |
|||
PO-0921 | Dose considerations of IGRT using MV projection and MV CBCT on a prototype linear accelerator | Peter Balter | ![]() |
![]() |
|||
PO-0922 | Late toxicity and cosmetic outcome following APBI using interstitial multicatheter HDR brachytherapy | Tamer Soror | ![]() |
![]() |
|||
PO-0924 | HDR BOOST IN cT3 BREAST CARCINOMA WITH NEOADJUVANT CHEMOTHERAPY AND CONSERVING THERAPY | Fabiola Romero Ruperto | ![]() |
![]() |
|||
PO-0925 | Timing of post-implant analysis in permanent breast seed implant: results from a serial CT study | Elizabeth Watt | ![]() |
![]() |
|||
PO-0926 | Interstitial HDR prostate brachytherapy: comparison of pre- and post-implant dose distribution. | Sergey Novikov | ![]() |
![]() |
|||
PO-0927 | Plug-free needles provide dosimetric advantages over plugged needles in I-125 prostate brachytherapy | AHAMED BADUSHA MOHAMED YOOSUF | ![]() |
![]() |
|||
PO-0928 | Androgen deprivation therapy influences PSA bounce rate after brachytherapy | Wojciech Burchardt | ![]() |
![]() |
|||
PO-0929 | Needle Migration in HDR Brachytherapy for Prostate Cancer evaluated by Serial MRI and Photos | Simon Buus | ![]() |
![]() |
|||
PO-0930 | CT to TRUS based Prostate HDR: what is the optimal dosimetric margin to use? | Frédéric Lacroix | ![]() |
![]() |
|||
PO-0931 | Clinical outcome and quality of life after MRI-guided HDR boost for prostate cancer. | Ferenc Lakosi | ![]() |
![]() |
|||
PO-0932 | Prostate-specific Antigen bounce in patients treated with 125I prostate brachytherapy: Keep calm | Andreia Pires | ![]() |
![]() |
|||
PO-0933 | Urethral dose in cervical image guided brachytherapy | Kirsty MacLennan | ![]() |
![]() |
|||
PO-0934 | Brachytherapy as part of the conservative treatment for primary and recurrent vulvar carcinoma | Pauline Castelnau-Marchand | ![]() |
![]() |
|||
PO-0936 | Dose effects of draining rectal gas in image-guided brachytherapy for gynecological cancer | Hideko Takase | ![]() |
![]() |
|||
PO-0937 | HDR image-guided interstitial brachytherapy for postoperative local recurrent uterine cancer | Ken Yoshida | ![]() |
![]() |
|||
PO-0939 | Comparison of brachytherapy sources of endometrial cancer: Electronic brachytherapy source and 192Ir | Sergio Lozares | ![]() |
![]() |
|||
PO-0940 | 3D mapping for precise definition of GTV, CTV and their correlation in cervix cancer BT (EMBRACE) | Susovan Banerjee | ![]() |
![]() |
|||
PO-0942 | In vivo dosimetry for cervix HDR brachytherapy - feasibility study using a MOSFET | Josh Mason | ![]() |
![]() |
|||
PO-0943 | Evaluation of a recent in vivo dosimetry methodology for HDR prostate BT using MOSFET detectors | Rosa Fabregat Borrás | ![]() |
![]() |
|||
PO-0944 | DOSIMETRIC INFLUENCE PRODUCED BY THE PRESENCE OF AN AIR GAP BETWEEN THE SKIN AND THE FREIBURG FLAP | MANUEL FERNÁNDEZ MONTES | ![]() |
![]() |
|||
PO-0946 | Entropic model for real-time dose calculation: application for I-125 prostate brachytherapy | Gabriele BIRINDELLI | ![]() |
![]() |
|||
PO-0947 | Image-guided brachytherapy with 106Ru eye plaques for uveal melanomas using post implantation MRI | Gerd Heilemann | ![]() |
![]() |
|||
PO-0948 | Role of HDR Intraluminal Brachytherapy in carcinoma Esophagus: An institutional experience. | Prashanth Kainthaje Bhat | ![]() |
![]() |
|||
PO-0949 | Evaluation of role of Interstitial Brachytherapy in Soft Tissue Sarcoma: Single institute experience | VIBHAY PAREEK | ![]() |
![]() |
|||
PO-0950 | High-dose-rate brachytherapy treatment in T1-T2 stage non-melanoma skin cancer patients. | Maria Ángeles González Ruiz | ![]() |
![]() |
|||
PO-0951 | Episcleral Brachytherapy for Uveal Melanoma | Andreia Ponte | ![]() |
![]() |
|||
PO-0952 | Integral heart dose and lymphocytopaenia in lung cancer patients treated with radical radiotherapy | Nuradh Joseph | ![]() |
![]() |
|||
PO-0953 | Proteome profiles in PDAC patients with local recurrence after postoperative radiochemotherapy | Louisa Bolm | ![]() |
![]() |
|||
PO-0955 | Co-treatment of MSC and vascular permeability inhibitor reduces radiation side effects on the colon | Virginie Monceau | ![]() |
![]() |
|||
PO-0956 | Prediction of irradiated cells fate: the necessity to revisit RBE by multi-parametric investigations | Vincent PAGET | ![]() |
![]() |
|||
PO-0957 | Radiobiological studies in in vitro reconstituted squamous epithelia | Georgeta Zemora | ![]() |
![]() |
|||
PO-0958 | Radiogenomics: role of non-coding RNA genes in increased radiotherapy sensitivity | Laura Duran-Lozano | ![]() |
![]() |
|||
PO-0960 | Radiobiological effectiveness and its role in modelling secondary cancer risk for proton therapy | Abdossalam Madkhali | ![]() |
![]() |
|||
PO-0961 | DNA damage and repair influence tumor sensitivity to diffusing alpha emitters radiation therapy | Yona Keisari | ![]() |
![]() |
|||
PO-0962 | Proton minibeam irradiation leads to reduced acute side effects in an in-vivo mouse ear model | Esther Zahnbrecher | ![]() |
![]() |
|||
PO-0963 | RBE variations along the Bragg curve of a 200 MeV proton beam | Charlot Vandevoorde | ![]() |
![]() |
|||
PO-0964 | Biomarkers in wound drainage fluids affect response to radiations of head and neck cancer cells | Mariangela Sottili | ![]() |
![]() |
|||
PO-0966 | Prognostic value of tissue necrosis, hypoxia-related markers in head and neck cancer patients treated with bio- or chemo-radiotherapy | Dan Ou | ![]() |
![]() |
|||
PO-0967 | Analysis of tumour microenvironment using multi-parametric PET/MR imaging in HNSCC xenograft models | Simon Boeke | ![]() |
![]() |
|||
PO-0968 | The Role of epithelial to mesenchymal transition (EMT) as Biomarker for Radioresistance in HNSCC | Ina Kurth | ![]() |
![]() |
|||
PO-0970 | Prostate brachytherapy; DNA damage biomarker (gH2AX) induction rate correlates with late toxicity | Sarah O S Osman | ![]() |
![]() |
|||
PO-0974 | Biomarkers of radiosensitivity for patient stratification and personalized radiotherapy treatment | Elisa Palumbo | ![]() |
![]() |
|||
PO-0975 | Clinical utilization of the radiation-hypoxia-induced abscopal/bystander effect | Slavisa Tubin | ![]() |
![]() |
|||
PO-0976 | Mechanisms of normal tissue toxicity from SAHA, an HDAC inhibitor and radiosensitizer | Imon Barua | ![]() |
![]() |
|||
PO-0977 | Plasma lipidomics for predictive biomarker analysis in rectal cancer. | Philippe Bulens | ![]() |
![]() |
|||
PO-0978 | Potential predictive biomarkers to chemoradiotherapy response in rectal cancer: a lipidomic study. | Francesca Perrotti | ![]() |
![]() |
|||
PO-0979 | Differential response of glioma cell lines to microbeam versus conventional radiotherapy | Lloyd Smyth | ![]() |
![]() |
|||
PO-0980 | MEK/ERK pathway sustains radioresistance of embryonal rhabdomyosarcoma stem-like cell population. | Francesco Marampon | ![]() |
![]() |
|||
PO-0981 | Disturbance of redox status enhances radiosensitivity of hepatocellular carcinoma | Hong Zhang | ![]() |
![]() |
|||
PO-0985 | Tumor metabolic changes after neoadjuvant radiotherapy: consequences for surgery-related metastases | philippe martinive | ![]() |
![]() |
|||
PO-0987 | Gemcitabine-based chemoradiotherapy gets improved with PARP inhibitor in pancreatic cancer cells | waisse WAISSI | ![]() |
![]() |
|||
PO-0988 | Following tumour microenvironment after Neoadjuvant radiotherapy with IVIM perfusion analysis | Philippe Martinive | ![]() |
![]() |
|||
PO-0990 | Combining radiotherapy and notch inhibition in melanoma | Kamalram Thippu Jayaprakash | ![]() |
![]() |
|||
PO-0991 | Chromosomal radiosensitivity and genomic instability of Fanconi anaemia patients in South Africa | Flavia Zita Francies | ![]() |
![]() |
|||
PO-0992 | Low-dose whole lung irradiation plus Re-188-liposome eliminates lung metastasis of esophageal cancer | Yu-Jen Chen | ![]() |
![]() |
|||
PO-0993 | Influence of radiotherapy on differentiation, maturation and functionality of dendritic cells | Laila Knig | ![]() |
![]() |
|||
PO-0994 | Integrin antagonistic drugs reveal different effectiveness in 2D monolayer vs. 3D spheroid culture | Verena Kopatz | ![]() |
![]() |
|||
PO-0996 | Accuracy of an optical surface monitoring device to reduce imaging of breast cancer patients | Josh Sharpe | ![]() |
![]() |
|||
PO-0997 | Improving shoulder positioning in a 5-points mask. | LJ Mesch | ![]() |
![]() |
|||
PO-0998 | Comparison of the accuracy of different pillow for radiation therapy of head and neck cancer | Chun Yen Lin | ![]() |
![]() |
|||
PO-0999 | Control of rectal volume with Kampo formula during prostate radiotherapy: A prospective study | Jin Kobayashi | ![]() |
![]() |
|||
PO-01000 | Immobilisation systems for brain treatment: are individual head supports needed for stable fixation? | Simone Meessen | ![]() |
![]() |
|||
PO-1001 | Evaluation of target volume delineation of the regional lymph nodes in breast cancer patients | Mirjam Mast | ![]() |
![]() |
|||
PO-1002 | Comparison of Best Commercial Model and Atlas based segmentation with CT and MR in brain cancer. | Joong-Yeol Woo | ![]() |
![]() |
|||
PO-1003 | Radiological Features of Brain Metastases in a Single Center Population: An Implication for the HA-WBRT Approach | YiMin Han | ![]() |
![]() |
|||
PO-1004 | Machine learning methods for automated OAR segmentation | Pal Tegzes | ![]() |
![]() |
|||
PO-1005 | Automatic segmentation of cardiac sub-structures in the treatment of HL | Christian Fiandra | ![]() |
![]() |
|||
PO-1006 | Evaluation of an auto-segmentation software for definition of organs at risk in radiotherapy | Maria Dolores Herraiz Lablanca | ![]() |
![]() |
|||
PO-1007 | The effect of VMAT on tumor coverage and organs at risk for head and neck cancer patients | Michelle Kertevig | ![]() |
![]() |
|||
PO-1008 | Feasibility of stereotactic ablative radiotherapy for locally-advanced non-small cell lung cancer | Katrina Woodford | ![]() |
![]() |
|||
PO-1009 | Evaluation of setup margins using cone-beam CT for prostate and pelvic nodes irradiation | Aniek van Nunen | ![]() |
![]() |
|||
PO-1010 | Investigation of reproducibility of bolus position based on kV CBCT imaging | Edyta D&261;browska | ![]() |
![]() |
|||
PO-1011 | Is it safe to omit a setup correction validation scan for central lung lesions treated with SBRT? | Maddalena M.G. Rossi | ![]() |
![]() |
|||
PO-1012 | Traffic Light Protocol as a guide for optimal registration of LACC complex tumor pathology | Evelien Bogaert | ![]() |
![]() |
|||
PO-1013 | Library of plans and CTV-PTV margins for VMAT irradiation of cervical cancer | Petronella Maria Kager | ![]() |
![]() |
|||
PO-1014 | Target volume motion during anal cancer IGRT using cone-beam CT | Corrinne Brooks | ![]() |
![]() |
|||
PO-1016 | Impact of CBCT based IGART strategies on margins in postoperative IMRT of gynecological tumors | Monica Buijs | ![]() |
![]() |
|||
PO-1017 | Dose guided adaptive radiotherapy based on cumulated dose in OAR for prostate cancer | Mohamed Nassef | ![]() |
![]() |
|||
PO-1018 | Improvement of radiation-induced late toxicity after hyperbaric oxygen treatment | Raquel Roncero | ![]() |
![]() |
|||
PO-1019 | Mobile Oncology: Survey with Healthcare Professionals about Telemedicine, mHealth and mobile Apps | Kerstin Kessel | ![]() |
![]() |
|||
PO-1020 | Re-irradiation of Head and Neck sarcomas: initial results of Protontherapy Center of Trento, Italy | Irene Giacomelli | ![]() |
![]() |
|||
PO-1021 | An electronically configurable checklist program for quality control of RT treatment planning | Karl-Heinz Grosser | ![]() |
![]() |
|||
PO-1022 | Implementation of a paperless workflow in radiotherapy; Reducing transcription | Oliver Shoffren | ![]() |
![]() |
|||
PO-1023 | Reducing waiting room times - A 5 year review of an in-house KPI tool | Andrew Wallis | ![]() |
![]() |
|||
PO-1024 | Effectiveness of couch coordinate constraints to reduce error rates in radiation therapy delivery | Olaf Nairz | ![]() |
![]() |
|||
PO-1025 | Development of a in-house KPI tool | Andrew Wallis | ![]() |
![]() |
|||
EP-1027 | Evaluation of induction chemotherapy followed by radiation therapy in advanced oropharyngeal cancers | RAVIKIRAN POTHAMSETTY | ![]() |
![]() |
|||
EP-1028 | MRI during radiotherapy: tumor geometry and changes in organs at risk for head-and-neck patients | chaline grundmann | ![]() |
![]() |
|||
EP-1029 | Improved interobserver reproducibility in nasopharyngeal tumor delineation using a reference GTV | Ariane Lapierre | ![]() |
![]() |
|||
EP-1030 | External beam radiation therapy for locoregionally recurrent differentiated thyroid carcinoma | Chul-Yong Kim | ![]() |
![]() |
|||
EP-1031 | FDG-PET/CT as a guide for Intensity-Modulated Radiation Treatment of advanced head and neck cancer | Francesco Ricchetti | ![]() |
![]() |
|||
EP-1032 | Optimising head and neck radiotherapy for dental rehabilitation | Sean OCathail | ![]() |
![]() |
|||
EP-1033 | Survival patterns in elderly patients with head and neck squamous cell carcinoma treated with definitive radiotherapy | Linda Sommers | ![]() |
![]() |
|||
EP-1034 | Significance of mutant p53 and Ki67 as predictive biomarkers post Chemo-RT in locally advanced HNSCC | Priya Baskaran Shanmuga | ![]() |
![]() |
|||
EP-1035 | Dose-volume analysis of the hypoglossal nerve and its correlation with Dysarthria-Dysphagia Syndrome | FEN CHEN | ![]() |
![]() |
|||
EP-1036 | 18F-FDG-PET in Guiding Dose-painting with IMRT in Oropharyngeal Tumours (FiGaRO) Swallow Results | Carolyn Doughty | ![]() |
![]() |
|||
EP-1037 | Chronic radiation-associated dysphagia (RAD) after curative reirradiation in head and neck cancer | Lucia Gutierrez Bayard | ![]() |
![]() |
|||
EP-1038 | Intraoperative electron beam radiotherapy for locoregionally recurrent head and neck cancer | Patrick Wald | ![]() |
![]() |
|||
EP-1039 | CTV growth evaluation for involved site neck lymphoma RT if pre-chemo RT position PET-CT is absent | David Bird | ![]() |
![]() |
|||
EP-1040 | Identifying risk factors for LHermittes syndrome after chemo-IMRT for head and neck cancer | Hannah Laidley | ![]() |
![]() |
|||
EP-1041 | The Preliminary Report of PG2 in Improving QoL of Pharyngeal Cancer Patients in Chemoradiotherapy | Hung-Ming Wang | ![]() |
![]() |
|||
EP-1042 | Olfactory neuroblastoma 10-year experience with volumetric modulated arc therapy | Hemal Ariyaratne | ![]() |
![]() |
|||
EP-1043 | Chemo-reirradiation with simultaneously integrated boost in patients with local recurrence of HNSCC | Aleksei Mikhailov | ![]() |
![]() |
|||
EP-1044 | Survival and functional outcome after treatment for primary base of tongue cancer | Sangjoon Park | ![]() |
![]() |
|||
EP-1046 | HYPOFRACTIONATED PALLIATIVE RADIOTHERAPY IN HEAD AND NECK CANCER | Pilar Vargas Arrabal | ![]() |
![]() |
|||
EP-1047 | Comparison of TPF and CF induction chemoradiotherapy for radical treatment of head and neck cancer. | Carl Adkin | ![]() |
![]() |
|||
EP-1048 | Phantom Tumour Phenomenon in Nasopharyngeal Carcinoma Patients after Radiotherapy | Yee-Min Jen | ![]() |
![]() |
|||
EP-1049 | Intensity-Modulated Radiotherapy(IMRT) could provide better outcomes for nasopharyngeal carcinoma. | Poompis Pattaranutaporn | ![]() |
![]() |
|||
EP-1050 | Prognostic factors analysis in advanced SCCHN treated by induction chemotherapy/local therapy | Chingte Wu | ![]() |
![]() |
|||
EP-1051 | Characteristics and Impact of HPV to Head and Neck Squamous Cell Carcinoma in Thai Patients | CHULEEPORN JIARPINITNUN | ![]() |
![]() |
|||
EP-1052 | Hypofractionated vs. conventional radiotherapy for early glottic cancer: a propensity score analysis | Wataru Takahashi | ![]() |
![]() |
|||
EP-1053 | Analysis of outcomes of Adenoid cystic Carcinoma of Head and Neck region: Single Institution Study | Milan Anjanappa | ![]() |
![]() |
|||
EP-1054 | Disease Outcomes following Post-operative IMRT for Oral Cavity Cancer: A Single Institution Analysis | Andriana Michaelidou | ![]() |
![]() |
|||
EP-1055 | A Novel Postoperative Chemoradiotherapy Protocol versus Conventional CCRT for High-risk SCCHN | Yi-Ting Shih | ![]() |
![]() |
|||
EP-1056 | Radiation and concurrent superive intra-arterial cisplatin for maxillary sinus cancer | Takeshi Ebara | ![]() |
![]() |
|||
EP-1057 | Predictive and prognostic value of pretreatment 18F FDG-PET parameters in head-and-neck cancer | Letizia Deantonio | ![]() |
![]() |
|||
EP-1058 | A multicenter study of carbon-ion RT for locally advanced olfactory neuroblastomas (J-CROS1402HN) | Hiroaki Suefuji | ![]() |
![]() |
|||
EP-1059 | A 18F FDG-PET adaptive thresholding algorithm for delineation of RT volumes of head&neck cancer. | Letizia Deantonio | ![]() |
![]() |
|||
EP-1061 | Towards a validated Decision Aid Tool for advanced larynx cancer patients | Adriana Berlanga | ![]() |
![]() |
|||
EP-1062 | Hypofractionated vs standard radical radiotherapy in early (Tis-T1,T2) glottic cancer patients. | Maria Ángeles González Ruiz | ![]() |
![]() |
|||
EP-1063 | Epidemiology and clinical outcome of HPV in different head and neck cancer a subgroup analysis | Edwin Boelke | ![]() |
![]() |
|||
EP-1064 | Does parotid sparing adaptive radiotherapy (PSART) benefit patients? Interim results of the PARITY study | Chandran Nallathambi | ![]() |
![]() |
|||
EP-1065 | Prediction of Dysphagia and Xerostomia based on CT imaging features of HNSCC Patients | Karoline Pilz | ![]() |
![]() |
|||
EP-1066 | Hypofractionated accelerated SIB-VMAT radiotherapy for H&N cancer: brachial plexus constraint | Gabriella Macchia | ![]() |
![]() |
|||
EP-1067 | is adenoid cystic carcinoma (ACC) radioresistant?: the effect of radiotherapy for ACC of head & neck | INHYE JUNG | ![]() |
![]() |
|||
EP-1068 | Hypoxic imaging obtained at 2-h postinjection in FMISO-PET | Mitsue Kawamura | ![]() |
![]() |
|||
EP-1069 | Survival-weight health profile in nasopharyngeal cancer patients | Chia Hsuan Lai | ![]() |
![]() |
|||
EP-1070 | Concurrent chemoradiation versus upfront surgery for clinical T3-4 laryngeal and hypopharyngeal cancer | Yoo Gyu Sang | ![]() |
![]() |
|||
EP-1071 | Organ-sparing SBRT in reirradiation of head and neck cancer: efficacy, toxicity, and quality of life | Isabella Zhang | ![]() |
![]() |
|||
EP-1072 | Early nutritional support in head & neck: survey of Italian radiation oncologists/otolaryngologists. | Marianna Trignani | ![]() |
![]() |
|||
EP-1074 | Dose impact using standard head and neck immobilization system in brain tumours | magnolia rincon | ![]() |
![]() |
|||
EP-1075 | Role of Diffusion Weighted Imaging in Laryngeal & Hypopharyngeal Cancers treated with Radiotherapy | Simon Pavamani | ![]() |
![]() |
|||
EP-1076 | toxicity of concomitant chemotherapy and IMRT in locally advanced OPSCC: sequential vs SIB technique | Gessica Abate | ![]() |
![]() |
|||
EP-1077 | Predictive modeling for radiation-induced acute dysphagia in head and neck cancer patients. | Daniela Alterio | ![]() |
![]() |
|||
EP-1078 | Transient xerostomia in head and neck cancers with significant parotid inclusion in target volume | Anupam Datta | ![]() |
![]() |
|||
EP-1079 | Carotid blowout syndrome after reirradiation with particle therapy in the head and neck region | Jon Espen Dale | ![]() |
![]() |
|||
EP-1080 | Psychological distress in patients with head and neck cancer during radiotherapy | Mariangela Massaccesi | ![]() |
![]() |
|||
EP-1081 | Tumor response after palliative radiotherapy in head and neck cancer and its influence on survival | Mafalda Cruz | ![]() |
![]() |
|||
EP-1082 | Primary surgery vs. radiotherapy in early-stage oropharyngeal cancer: a single centre experience | Catia Pedro | ![]() |
![]() |
|||
EP-1083 | HPV as an etiological and prognostic factor for the Polish patients with HNC. | Adam Brewczynski | ![]() |
![]() |
|||
EP-1085 | Comparative study of outcomes and toxicities in conventional 2DRT vs IMRT in locally advanced HNSCC | Karthik Periasamy | ![]() |
![]() |
|||
EP-1086 | Health status and phisical activity in head and neck cancer survivors | Ángela Matías-Pérez | ![]() |
![]() |
|||
EP-1087 | Real-world Cetuximab toxicity in curative and recurrent/metastatic setting in HNSCC patients. | Isacco Desideri | ![]() |
![]() |
|||
EP-1088 | EGFR as blood biomarker improves prognostic value of nomogram for survival in laryngeal carcinoma | Frederik Wesseling | ![]() |
![]() |
|||
EP-1089 | Prospective study of body composition changes during IMRT for H&N cancer as assessed by DXA scans | Jrgen Johansen | ![]() |
![]() |
|||
EP-1090 | Particle therapy and IMRT for patients with esthesioneuroblastoma: a single-institution experience | Jakob Liermann | ![]() |
![]() |
|||
EP-1092 | Perioperative high dose rate brachytherapy in previously irradiated head and neck cancer: Results | Maria Isabel Martínez Fernández | ![]() |
![]() |
|||
EP-1093 | Hypofractioned robotic stereotactic radiotherapy of Head and neck Paragangliomas | FATIMA MENIAI | ![]() |
![]() |
|||
EP-1094 | Transoral Laser Microsurgery associated to Radiotherapy in advanced laryngeal carcinomas. | Iñigo Nieto Regueira | ![]() |
![]() |
|||
EP-1096 | Loco-regional failures in patients with head and neck cancer and where to find them using Deformable Image Registration | Yaolin Zheng | ![]() |
![]() |
|||
EP-1097 | Medical or surgical management for oropharyngeal cancer:how far p16 expression can be used in decision process? | Anouchka Modesto | ![]() |
![]() |
|||
EP-1098 | Survival predictors in patients with head and neck cancer treated with surgical resection | Gustavo Marta | ![]() |
![]() |
|||
EP-1099 | Evaluation of laryngeal preservation & outcomes following RT for locally advanced laryngeal SCC | Julianne OShea | ![]() |
![]() |
|||
EP-1101 | Leptomeningeal spread after stereotactic radiation for brain metastases from breast cancer | Orit Kaidar-Person | ![]() |
![]() |
|||
EP-1102 | Prognostic factors of gliosarcoma a single institution study | Hyun Ju Kim | ![]() |
![]() |
|||
EP-1103 | Are hippocampi considered organs at risks during stereotactic radiotherapy for brain metastases? | Umberto Tebano | ![]() |
![]() |
|||
EP-1104 | SABR for brain metastases with VMAT and FFF: feasibility and early clinical results | Niccolò Giaj Levra | ![]() |
![]() |
|||
EP-1105 | Treatment Outcomes and Prognostic Factors of Atypical Meningioma: A Single-Institution Experience | Hye Jin Kang | ![]() |
![]() |
|||
EP-1106 | Local control and overall survival after frameless radiosurgery | Angelika Bilger | ![]() |
![]() |
|||
EP-1107 | Treatment Strategies for local and distant recurrence after HFSRT of the Resection Cavity | Angelika Bilger | ![]() |
![]() |
|||
EP-1108 | CyberKnife stereotactic radiation therapy for re-irradiation of recurrent high grade gliomas. | Hanna Grzbiela | ![]() |
![]() |
|||
EP-1109 | measurement of hippocampus atrophy after whole brain irradiation using voxel based morphometry | Takeshi Ito | ![]() |
![]() |
|||
EP-1110 | Evaluation of 18FFET-PET and MRI assessed recurrence pattern in patients with high-grade glioma | Josefine Hesse | ![]() |
![]() |
|||
EP-1112 | DOSIMETRIC EVALUATION in TRI-COBALT60 VIEWRAY SYSTEM FOR HYPOFRACTIONATED IMRT IN BRAIN METASTASES | Francesco Catucci | ![]() |
![]() |
|||
EP-1113 | Helical Tomotherapy and altered fractionation in the treatment of Glioblastoma | Cristina Caruso | ![]() |
![]() |
|||
EP-1114 | A prospective multicenter feasibility trial of Spine Stereotactic Body Radiation Therapy | Hiroshi Tanaka | ![]() |
![]() |
|||
EP-1115 | LINAC vs VIEWRAY IN BRAIN METASTASES: A DOSIMETRIC COMPARISON OF HYPOFRACTIONATED IMRT AND VMAT | Francesco Catucci | ![]() |
![]() |
|||
EP-1116 | Reirradiation and concurrent bevacizumab high-grade recurrent gliomas: experience and perspectives. | Antoine Schernberg | ![]() |
![]() |
|||
EP-1117 | Sequential Proton Boost after Standard Chemoradiation for High-Grade Glioma | Sebastian Adeberg | ![]() |
![]() |
|||
EP-1118 | Radiotherapy-related endocrine dysfunction in patients treated for craniopharyngioma | Nicolette Taku | ![]() |
![]() |
|||
EP-1119 | Radiosurgery for meningioma:Evaluation of radiological outcome and factors of recurrence | shaghayegh hassas yeganeh | ![]() |
![]() |
|||
EP-1120 | FRACTIONATED STEREOTACTIC RADIOTHERAPY IN ADULT CRANIOPHARYNGIOMAS : OUTCOMES AND COMPLICATIONS. | Raquel Benlloch Rodríguez | ![]() |
![]() |
|||
EP-1121 | Newly diagnoses grade III glioma patients: evaluation of factors conditioning outcome. | Pierina Navarria | ![]() |
![]() |
|||
EP-1122 | TSPO PET imaging RT treatment planning in malignant glioma | Daniel Fleischmann | ![]() |
![]() |
|||
EP-1123 | To contour or not contour hippocampus in stereotactic brain radiotherapy? A dosimetric study. | CLELIA DI CARLO | ![]() |
![]() |
|||
EP-1124 | PET-MRI prior to re-irradiation of high-grade glioma patients - a planning study | Daniel Fleischmann | ![]() |
![]() |
|||
EP-1125 | Concomitant temozolomide therapy improves survival outcome of patients with multifocal glioblastoma | Mustafa Syed | ![]() |
![]() |
|||
EP-1126 | Whole brain radiotherapy of breast cancer brain metastases: intracranial progression and prognosis. | Dan Ou | ![]() |
![]() |
|||
EP-1127 | Dose to hippocampus in brain metastases radiosurgery: need for an hippocampal sparing approach | Silvia Scoccianti | ![]() |
![]() |
|||
EP-1128 | Stereotactic radiotherapy or whole brain with simultaneous integrated boost in brain metastases? | Francesco Beghella Bartoli | ![]() |
![]() |
|||
EP-1129 | Fractionated stereotactic radiotherapy for the treatment of cavernous sinus meningiomas | Isabel Tovar Martin | ![]() |
![]() |
|||
EP-1130 | Hippocampus Dosimetry in patients treated with Stereotactic Radiosurgery for Brain Metastases | Najmus Sahar Iqbal | ![]() |
![]() |
|||
EP-1131 | Evaluation of overall survival following SRS for non-small cell lung cancer brain metastases | Sean All | ![]() |
![]() |
|||
EP-1132 | Hypofractionated Stereotactic Reirradiation for Recurrent High-grade Glioma | Ludmila Hynkova | ![]() |
![]() |
|||
EP-1133 | Multifraction Radiosurgery for Large Brain Metastasis: Initial Results from Brazilian Experience. | Allisson Borges | ![]() |
![]() |
|||
EP-1134 | Head and neck DLBCL in HIV-positive patients: long-term results in the HAART era | Francesca De Felice | ![]() |
![]() |
|||
EP-1135 | Radiotherapy in primary CNS lymphoma | ROBERTA MUNI | ![]() |
![]() |
|||
EP-1136 | Technical results of total skin irradiation using helical TomoTherapy. | Kae Okuma | ![]() |
![]() |
|||
EP-1137 | Meningeal localisation in Sezary Syndrome patient treated with VMAT craniospinal irradiation | ROBERTA MUNI | ![]() |
![]() |
|||
EP-1139 | ELIOT- BOOST AND CONSERVATIVE SURGERY FOLLOWED BY HYPOFRACTIONATED EBRT IN BREAST CANCER PATIENTS | SILVIA TAKANEN | ![]() |
![]() |
|||
EP-1140 | Dosimetric comparison between Helical Tomotherapy and IMRT for Bilateral Breast Cancer | Ming-Hua Wang | ![]() |
![]() |
|||
EP-1141 | Acute and late toxicity of IORT during BCS followed by whole breast radiotherapy (WBI). | Bartosz Urba&324;ski | ![]() |
![]() |
|||
EP-1142 | EORTC QLQ C-30 scores evolution in stage I-III breast cancer patients during sequential treatment | antonio vila | ![]() |
![]() |
|||
EP-1143 | Hypofractionated vs conventionally fractionated breast radiotherapy: Economic consequences. | Aura Cecilia Ciafre | ![]() |
![]() |
|||
EP-1144 | Old age impact on radiotherapy omission in breast cancer patients | Simona Cima | ![]() |
![]() |
|||
EP-1145 | Troponin I for the detection of cardiac toxicity in adjuvant breast cancer radiotherapy | Khadidja Boudaoud | ![]() |
![]() |
|||
EP-1147 | The onset of radiation induced oesophagitis in breast cancer patients | Katrina West | ![]() |
![]() |
|||
EP-1148 | Distress, use of psychological supportive care services and psychotropic drugs in early breast cancer: two Institutions comparison | Icro Meattini | ![]() |
![]() |
|||
EP-1149 | Omission of completion axillary lymph node dissection in patients underrepresented in ACOSOG Z11 | Brian Gebhardt | ![]() |
![]() |
|||
EP-1151 | Hypofractionated Radiotherapy in breast cancer treatment: A comparison between 3-DCRT and IMRT | Alba Fiorentino | ![]() |
![]() |
|||
EP-1152 | Intraoperative radiotherapy for early breast cancer: a monocentric experience | Gabriella Macchia | ![]() |
![]() |
|||
EP-1153 | Post-Mastectomy Hypofractionated Radiotherapy for Breast Cancer Treatment | Cindy Sharon Ortiz Arce | ![]() |
![]() |
|||
EP-1154 | Changes in skin microcirculation during radiation therapy for breast cancer to avoid any issues related to previous publication. Thank you for understanding. | Alexandru Dasu | ![]() |
![]() |
|||
EP-1155 | Outcomes of breast cancer patients older than 80 years treated with adjuvant radiotherapy | Michael Frelinghuysen | ![]() |
![]() |
|||
EP-1156 | A clinical trial on hypofractionated whole-breast irradiation after breast-conserving surgery | Miwako Nozaki | ![]() |
![]() |
|||
EP-1157 | Serial changes of post-lumpectomy seroma during MRI-guided partial breast irradiation | Seung Hyuck Jeon | ![]() |
![]() |
|||
EP-1158 | Vmat radiation induced nausea/vomiting in adjuvant breast cancer radiotherapy: dosimetrical issues. | Grazia Lazzari | ![]() |
![]() |
|||
EP-1159 | Hypofractionated adjuvant radiotherapy and concomitant trastuzumab for breast cancer: 5-year results | Andrei Fodor | ![]() |
![]() |
|||
EP-1160 | T4s for T4 small Breast cancer: a new TNM classification subgroup proposal | Wael Salem ZRAFI | ![]() |
![]() |
|||
EP-1161 | Hypofracionated Radiation Therapy in Breast Cancer: retrospective analysis of late toxicity | Patrizia Ferrazza | ![]() |
![]() |
|||
EP-1162 | Non surgical breast conserving treatment using a new radiosensitizer | Taiju Shimbo | ![]() |
![]() |
|||
EP-1163 | A Prospective Evaluation of Lumpectomy Cavity Volume Changes During Whole Breast Radiotherapy | Brandon Barney | ![]() |
![]() |
|||
EP-1164 | Improved accuracy in IORT with electron beams by a new measuring system of mammary gland thickness | PAOLO SCALCHI | ![]() |
![]() |
|||
EP-1165 | Short and long term safety of a post-mastectomy conformal electron beam radiotherapy (PMERT) | Noémie Grellier-Adedjouma | ![]() |
![]() |
|||
EP-1166 | Patterns of post-operative radiotherapy in breast cancer patients after neoadjuvant chemotherapy | Gustavo Marta | ![]() |
![]() |
|||
EP-1167 | Accelerated Partial Breast Irradiation: A single center analysis. | KILLIAN NUGENT | ![]() |
![]() |
|||
EP-1168 | male breast cancer; a review of patients treated from 2004 - 2013 (10yrs) | Pearl scott | ![]() |
![]() |
|||
EP-1169 | Preoperative CT scan in tumor bed delineation after breast conserving surgery and oncoplasty | Tripti Saxena | ![]() |
![]() |
|||
EP-1170 | Hypofractionated radiotherapy for ductal carcinoma in situ using VMAT: acute toxicity and cosmesis | Fiorenza De Rose | ![]() |
![]() |
|||
EP-1171 | Thermography and association to high-grade radiation dermatitis: a prospective trial on 64 patients. | Nicolas Leduc | ![]() |
![]() |
|||
EP-1172 | Post-mastectomy radiotherapy with patient-tailored bolus using 3D printing for left breast cancer | Kyungmi Yang | ![]() |
![]() |
|||
EP-1173 | Understanding variations in the use of hypofractionated radiotherapy for breast cancer: a mixed-methods study | Josep Maria Borras | ![]() |
![]() |
|||
EP-1174 | impact of radiotherapy to posterior supraclavicular and posterior triangle area in breast cancer | Shihhua Liu | ![]() |
![]() |
|||
EP-1175 | Impact of body-mass index on setup displacement in patients with breast cancer | Yi-Chieh Tsai | ![]() |
![]() |
|||
EP-1176 | Helical tomotherapy in chest wall/breast and draining node irradiation after breast cancer surgery | Valentina Lancellotta | ![]() |
![]() |
|||
EP-1177 | Late skin effects of radiotherapy after breast conserving surgery: analysis of possible predictive clinical factors | Angela Romano | ![]() |
![]() |
|||
EP-1178 | Breast radiotherapy without nodal irradiation in pT1-2 pN0-1 stage: prognostic factors and outcomes. | Clelia Di Carlo | ![]() |
![]() |
|||
EP-1179 | Target Volume Definition after Lumpectomy for Accelerated Partial Breast Irradiation (APBI) or Boost | Ilja Ciernik | ![]() |
![]() |
|||
EP-1180 | Whole breast radiotherapy in Lateral Decubitus position : efficacy and toxicity | Estelle Bronsart | ![]() |
![]() |
|||
EP-1181 | dose to non-routinely delineated risk organs in post left conservative surgery conformal breast RT | Mahmoud Abdelwahed | ![]() |
![]() |
|||
EP-1182 | Locoregional treatment of breast cancer with IMRT: a single center experience | Ivica Ratosa | ![]() |
![]() |
|||
EP-1183 | Initial Clinical Experience with a Noninvasive Breast Stereotactic Radiotherapy Device: the GammaPod | Cedric Yu | ![]() |
![]() |
|||
EP-1184 | HDR boost decreases the risk of breast failure in invasive breast ca. with close or involved margins | Jose-Luis Guinot | ![]() |
![]() |
|||
EP-1185 | Post-operative Irradiation after Nipple-Sparing or Skin-Sparing Mastectomy: An International Survey | Gustavo Marta | ![]() |
![]() |
|||
EP-1186 | Real-time intra-fraction motion in breast cancer radiotherapy: analysis of 1876 fractions using an optical surface scanner | Reitz Daniel | ![]() |
![]() |
|||
EP-1188 | DIBH radiotherapy in left-sided breast cancer patients using an optical surface scanning system | Stephan Schnecker | ![]() |
![]() |
|||
EP-1189 | Right Coroner Artery Assessment in Radiotherapy of Breast Cancer | Ayse Altinok | ![]() |
![]() |
|||
EP-1190 | Assessment of the dose to the heart and the LAD for the left breast radiotherapy | Dainius Burdulis | ![]() |
![]() |
|||
EP-1191 | Postmastectomy locoregional irradiation to temporary tissue-expander or permanent breast implant | Rosalinda Ricotti | ![]() |
![]() |
|||
EP-1192 | Assessment of quality of life in phase III clinical trials of radiation therapy in breast cancer | Gustavo Marta | ![]() |
![]() |
|||
EP-1193 | Hypofractionated external beam radiation therapy for breast cancer. The new standard? | Ins Nobre Góis | ![]() |
![]() |
|||
EP-1194 | Dose-volume relationship for acute skin erythema in patients undergoing breast irradiation | Tiziana Rancati | ![]() |
![]() |
|||
EP-1195 | Regional nodal recurrences after adjuvant breast radiotherapy are we covering the target? | Laura Beaton | ![]() |
![]() |
|||
EP-1196 | Possible use of genetic tests: lets consider the opinion of patients | Tiziana Rancati | ![]() |
![]() |
|||
EP-1197 | Results in Breast cancer Patients who Received adjuvant Radiation after Immediate Reconstruction | Alexandra Giraldo | ![]() |
![]() |
|||
EP-1198 | Low risk breast cancer patients supportive care needs and perceptions of follow-up care options | Jennifer Yin Yee Kwan | ![]() |
![]() |
|||
EP-1202 | A lot to a little or a little to a lot - dose-volume relationships in thoracic tumors | Christina Schrder | ![]() |
![]() |
|||
EP-1203 | Changes in pulmonary function after high dose intrathoracic radio(-chemo)therapy up to 74 Gy | Christina Schrder | ![]() |
![]() |
|||
EP-1204 | Treatment Outcomes and Patterns of Radiologic Injury after Tomotherapy-based SBRT for Lung Tumours | Stefano Arcangeli | ![]() |
![]() |
|||
EP-1205 | The prognostic role of Neutrophil-to-lymphocyte ratio in limited disease small-cell lung cancer | Lukas Ksmann | ![]() |
![]() |
|||
EP-1206 | FDG-PET/CT predictive parameters of early response after SABR for lung oligometastases | Rosario Mazzola | ![]() |
![]() |
|||
EP-1207 | Outcomes and prognostic factors in solitary brain metastasis from small cell lung cancer | Denise Bernhardt | ![]() |
![]() |
|||
EP-1208 | Concomitant chemoradiotherapy followed by stereotactic ablative boost in non small cell lung cancer | Jérme Doyen | ![]() |
![]() |
|||
EP-1210 | SBRT with FFF Beams and V-MAT for lung cancer. A mono-institutional experience. | Francesco Martucci | ![]() |
![]() |
|||
EP-1211 | How ed are patients in clinical trials of radiotherapy for non-small cell lung cancer? | Shalini Vinod | ![]() |
![]() |
|||
EP-1212 | Parenchymal and functional lung changes after stereotactic body radiotherapy for early-stage NSCLC | Juliane Hoerner-Rieber | ![]() |
![]() |
|||
EP-1213 | Long-term outcomes of Stereotactic Ablative Radiotherapy for stage I non-small cell lung cancer | Sumin Lee | ![]() |
![]() |
|||
EP-1214 | Stereotactic Ablative Radiotherapy in Clinical Stage I (5cm) Non-Small Cell Lung Cancer | WAN JEON | ![]() |
![]() |
|||
EP-1215 | Risk factors of radiation pneumonitis after SRT: the usefulness of the PTV to lung volume ratio. | Tomoko Ueyama | ![]() |
![]() |
|||
EP-1217 | lung cancer invading the vertebra: what is the optimal strategy for radiation? | sarit appel | ![]() |
![]() |
|||
EP-1218 | Prognostic Values of Tumor Markers in Lung Cancer Patients Treated with Definitive Chemoradiotherapy | Joohyun Chung | ![]() |
![]() |
|||
EP-1219 | Concomitant radiotherapy and TKI in EGFR mutant or ALK positive stage IV non-small cell lung cancer | Marco Lorenzo Bonù | ![]() |
![]() |
|||
EP-1220 | Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy | Rebecca Btof | ![]() |
![]() |
|||
EP-1221 | ADHERENCE TO LUNG CANCER GUIDELINES AND ITS IMPACT ON SURVIVAL | Isabel Linares | ![]() |
![]() |
|||
EP-1222 | Beclin-1 expression of circulating tumor cells in non-small cell lung cancer patients. | Cristina Prieto Prieto | ![]() |
![]() |
|||
EP-1223 | Comparing concurrent versus sequential chemoradiotherapy in locally advanced NSCLC | Wei Guo | ![]() |
![]() |
|||
EP-1224 | Therapeutic effects of accelerated hyperfractionation and conventional fractionation CRT on NSCLC | Takamasa Mitsuyoshi | ![]() |
![]() |
|||
EP-1226 | Stereotactic robotic body radiotherapy for patients with pulmonary oligometastases | Patrick Berkovic | ![]() |
![]() |
|||
EP-1227 | Neutrophil-lymphocyte ratio and a dosimetric factor for predicting symptomatic radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent chemoradiotherapy | Yun Hee Lee | ![]() |
![]() |
|||
EP-1228 | UK NCRI CTRad consensus on drug and radiotherapy combination platform studies in NSCLC | Gerard Hanna | ![]() |
![]() |
|||
EP-1229 | Phase II trial of concurrent erlotinib in locally advanced non-small cell lung cancer (LA-NSCLC) | Olfred Hansen | ![]() |
![]() |
|||
EP-1230 | Post-operative radiotherapy (PORT) in patients with NSCLC | Tanja Schimek-Jasch | ![]() |
![]() |
|||
EP-1231 | Early Clinical outcome of the first lung SBRT program in a developing country | Shada Wadi-Ramahi | ![]() |
![]() |
|||
EP-1232 | Patient-reported toxicity in twice-daily (BID) versus once-daily (OD) chemoradiotherapy for LS-SCLC | Joyce Lodeweges | ![]() |
![]() |
|||
EP-1234 | Prophylactic Cranial Irradiation (PCI) in Small-Cell Lung Cancer: a single-institution experience. | Marek Konkol | ![]() |
![]() |
|||
EP-1235 | Stereotactic body radiotherapy for lung metastases: retrospective analysis of a single-center | Harald Herrmann | ![]() |
![]() |
|||
EP-1236 | Validation of the clinical diagnostic method for solitary pulmonary nodules before SBRT in Navarra | Maider Campo | ![]() |
![]() |
|||
EP-1239 | SBRT in patients with HCC/CCC or oligometastatic liver disease | Sabine Gerum | ![]() |
![]() |
|||
EP-1240 | Stereotactic radiotherapy in pancreatic cancer: a systematic review on pain relief | Gabriella Macchia | ![]() |
![]() |
|||
EP-1241 | SUCCESSFUL PAIN RELIEF AFTER A SHORT COURSE OF PALLIATIVE RADIOTHERAPY IN PAINFUL PANCREATIC CANCER. | Gati Ebrahimi | ![]() |
![]() |
|||
EP-1242 | Palliative EBRT for incurable esophageal cancer and symptomatic dysphagia-single center results | kaloyan yordanov | ![]() |
![]() |
|||
EP-1244 | Neoadjuvant Chemo Radiation followed by Surgery in Ca Esophagus Retrospective Review from India | VINEETA GOEL | ![]() |
![]() |
|||
EP-1246 | Definitive chemoradiotherapy for esophageal cancer: the impact of histological subtypes on survival | Francine Voncken | ![]() |
![]() |
|||
EP-1248 | Adjuvant radiotherapy for gastric cancer patients underwent gastrectomy and D2 lymph node dissection | Yunong Wang | ![]() |
![]() |
|||
EP-1249 | Changes in normal liver volume after Hepatic Irradiation: Results from a prospective observational study | Karthick Rajamanickam | ![]() |
![]() |
|||
EP-1250 | Prognostic impact of post-surgery and post-adjuvant therapy in resected pancreatic adenocarcinoma | Gabriella Macchia | ![]() |
![]() |
|||
EP-1252 | Update of Stereotactic body radiation therapy for pancreatic adenocarcinoma: efficacy and safety | Xin Chen | ![]() |
![]() |
|||
EP-1253 | Interobserver variability in the target delineation of hepatocellular carcinoma. | Eleni Gkika | ![]() |
![]() |
|||
EP-1254 | DVH analysis of radiotherapy of upper gastrointestinal tumours: a model to predict toxicity. | Gian Carlo Mattiucci | ![]() |
![]() |
|||
EP-1255 | Early clinical results for esophageal brachytherapy using a novel multi-balloon HDR applicator | Amandeep Taggar | ![]() |
![]() |
|||
EP-1256 | Local ablative radiotherapy for liver metastasis: factors affecting local control and survival | Cordula Petersen | ![]() |
![]() |
|||
EP-1257 | A look at pre-operative MRI accuracy at predicting rectal cancer staging post chemoradiotherapy | KILLIAN NUGENT | ![]() |
![]() |
|||
EP-1258 | Comparing simultaneous vs sequential boost strategies during concurrent chemo-radiation for anal cancer: results of a retrospective observational study | ARCADIPANE FRANCESCA | ![]() |
![]() |
|||
EP-1261 | Hypofractionated radiotherapy for inoperable rectal cancer: A retrospective analysis 2007 to 2015 | Nur Abdul Satar | ![]() |
![]() |
|||
EP-1262 | EBRT And HDRBT in Rectal Cancer Patients Who Are Medically Unfit Or Refuse Surgery | Chi Leung Chiang | ![]() |
![]() |
|||
EP-1263 | Short course radiotherapy, surgery & chemotherapy for stage IV rectal cancer with liver metastasis. | Laura Díaz Gómez | ![]() |
![]() |
|||
EP-1264 | Metabolic response and change in CEA level in rectal cancer patients treated with neoadjuvant CRT | Taek-Keun Nam | ![]() |
![]() |
|||
EP-1265 | Image-guided IMRT with simultaneous integrated boost as per RTOG 0529 for the treatment of anal cancer | ARCADIPANE FRANCESCA | ![]() |
![]() |
|||
EP-1266 | In silico evaluation of subcutaneous skin dose associated to use of MRIdian MRI- 60Co System | Francesco Catucci | ![]() |
![]() |
|||
EP-1267 | In silico Evaluation of the impact of Magnetic Field on dose distribution using of MRIdian MRI- 60Co | Francesco Catucci | ![]() |
![]() |
|||
EP-1268 | Tumor response according to NK cell change during preoperative chemoradiotherapy in rectal cancer | Jaesung Heo | ![]() |
![]() |
|||
EP-1269 | Comparison of 2 and 3 arc VMAT versus fixed field IMRT and proton beam therapy in anal cancer | Camilla Kronborg | ![]() |
![]() |
|||
EP-1270 | Clinical outcome of non-metastatic rectal cancer patients with extremely high CEA level | DAEYOUNG KIM | ![]() |
![]() |
|||
EP-1271 | Is 3D-CRT still a valid option in radical radiochemotherapy of anal carcinoma in the era of IMRT? | SHAKIR SHAKIR | ![]() |
![]() |
|||
EP-1272 | Impact of Ki67 on pathological complete response rate after neoadjuvant CRT in cT3N0M0 rectal cancer | Gabriella Macchia | ![]() |
![]() |
|||
EP-1273 | Stereotactic body radiation therapy (SBRT) for pelvic re-irradiation | Yolanda Augustin | ![]() |
![]() |
|||
EP-1274 | Radiation dose escalation to increase pathological complete clinical response in locally advanced rectal cancer | Maria Ana Estornell Gualde | ![]() |
![]() |
|||
EP-1275 | PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER (LARC): PREDICTIVE FACTORS OF PATHOLOGICAL RESPONSE | Sabrina Montrone | ![]() |
![]() |
|||
EP-1276 | Clinic and radiobiology of hypofractionated radiotherapy for metastatic liver tumors. Pilot results. | Tomasz Latusek | ![]() |
![]() |
|||
EP-1277 | Optimising RT dose for anal cancer the development of three clinical trials in one platform | David Sebag-Montefore | ![]() |
![]() |
|||
EP-1278 | FMISO-PET & perfusion CT at baseline & week 2 CRT as predictive markers for response in rectal ca | Tessa Greenhalgh | ![]() |
![]() |
|||
EP-1279 | Tumor response after short course radiotherapy for rectal cancer: immediate versus delayed surgery | Mafalda Cruz | ![]() |
![]() |
|||
EP-1280 | Clinical outcomes of anal squamous cell carcinoma, treated with IMRT, using UK guidance. | Sameer Sengupta | ![]() |
![]() |
|||
EP-1281 | Feasibility and Toxicity analysis of dose-escalation by SIB/VMAT schedule in rectal cancer patients | Alessia Re | ![]() |
![]() |
|||
EP-1282 | CLINICAL AND PATHOLOGICAL PROGNOSTIC FACTORS IN LOCALLY ADVANCED RECTAL CANCER | Sabrina Montrone | ![]() |
![]() |
|||
EP-1283 | Short Course Radiation Therapy For Locally Advanced Rectal Cancer | João Casalta Lopes | ![]() |
![]() |
|||
EP-1284 | Impact of surgical delay after long-course radiochemotherapy in rectal cancer | Tnia Maria dos Santos Teixeira | ![]() |
![]() |
|||
EP-1285 | Neutrophilia in locally advanced cervical cancer: A novel biomarker for image-guided adaptive brachytherapy? | Alexandre Escande | ![]() |
![]() |
|||
EP-1286 | MRI vs clinical assessment in staging and prediction of recurrence in carcinoma cervix treatment | mintu abraham | ![]() |
![]() |
|||
EP-1287 | 10-Year outcomes on patients receiving radical radiotherapy for cervical cancer | Kin Woo | ![]() |
![]() |
|||
EP-1288 | Correlation between PET/CT primary tumor FDG uptake and lymph node metastases in cervical cancer | Gamze Ugurluer | ![]() |
![]() |
|||
EP-1289 | Use of image guided brachytherapy reduces late toxicity for elderly patients with cervical cancer | Daijiro Kobayashi | ![]() |
![]() |
|||
EP-1290 | Helical Tomotherapy plus Brachytherapy boost in cervical cancer: a double dose escalation | Gabriella Cattari | ![]() |
![]() |
|||
EP-1293 | Clinical outcome of prophylactic PAN irradiation for locally advanced cervical cancer | Kohei Fukuda | ![]() |
![]() |
|||
EP-1294 | Interfractional motion of vaginal cuff after hysterectomy in gynecologic cancer | SeokJoo Chun | ![]() |
![]() |
|||
EP-1295 | Role of postoperative adjuvant radiotherapy in early stage cervical cancer without high risk factors | Wonguen Jung | ![]() |
![]() |
|||
EP-1296 | Adjuvant radiotherapy in endometrial cancer: Volumetric Modulated Intensity Arc Therapy vs 3DRT | cristina iftode | ![]() |
![]() |
|||
EP-1297 | Update: Phase III randomised trial on electro-hyperthermia plus chemoradiation for cervical cancer | Carrie Minnaar | ![]() |
![]() |
|||
EP-1298 | Radiotherapy in invasive vaginal carcinoma: a systematic review | Gabriella Macchia | ![]() |
![]() |
|||
EP-1300 | Stereotactic radiotherapy for oligometastatic ovarian cancer patients: preliminary results. | Sara Ronchi | ![]() |
![]() |
|||
EP-1301 | Early toxicity for image guided adaptive radiochemotherapy including brachytherapy in cervix cancer | Yvette Seppenwoolde | ![]() |
![]() |
|||
EP-1302 | Acute toxicity of prophylactic para-aortic chemoradiation for cervical cancer treated in IMAT era | NAGARJUN BALLARI | ![]() |
![]() |
|||
EP-1303 | Clinical outcomes of patients with advanced cervical cancer and percutaneous nephrostomy : An audit | ROHAN SALUNKHE | ![]() |
![]() |
|||
EP-1305 | Hemoglobin monitoring in Endometrial Carcinoma: how preoperative anemia impacts overall survival. | Katarzyna Holub | ![]() |
![]() |
|||
EP-1306 | New pre-treatment eosinophiles-related ratios as predictive factors for OS in endometrial carcinoma. | Katarzyna Holub | ![]() |
![]() |
|||
EP-1307 | New neutrophils-related ratios as a novel predictive biomarkers for endometrial carcinoma. | Katarzyna Holub | ![]() |
![]() |
|||
EP-1308 | A prospective trial of hypofractionation salvage radiation therapy after radical prostatectomy | Petr Bulychkin | ![]() |
![]() |
|||
EP-1309 | Is it necessary to make a re-plan during IMRT for prostate cancer due to change in prostate size? | Osamu Tanaka | ![]() |
![]() |
|||
EP-1310 | 68Ga-PSMA-PET/CT imaging of localized prostate cancer patients for IMRT with integrated boost | Wolfram Laub | ![]() |
![]() |
|||
EP-1311 | Beyond IMRT for Prostate Cancer: The Effect of Modern Technique on Treatment Quality and Outcome | Amanda Zucker | ![]() |
![]() |
|||
EP-1312 | Long terms outcome in prostate cancer with image guided and intensity modulated radiation therapy. | Carmen Salas | ![]() |
![]() |
|||
EP-1313 | 18 F NaF PET use in prostate cancer staging in a single centre 2013-2016: retrospective review | Martin Higgins | ![]() |
![]() |
|||
EP-1315 | Prostate cancer lymph nodal disease: SBRT only or extensive prophylactic irradiation and boost? | Andrei Fodor | ![]() |
![]() |
|||
EP-1316 | Moderate Hypofractionation RT in post-prostatectomy setting:report on feasibility and acute toxicity | Sergio Fersino | ![]() |
![]() |
|||
EP-1317 | PET-guided pelvic re-irradiation for nodal recurrences of prostate cancer | Piet Dirix | ![]() |
![]() |
|||
EP-1318 | Is hypofractionation combined to WPRT effective in high risk prostate cancer patients? | Andrei Fodor | ![]() |
![]() |
|||
EP-1319 | Adjuvant/ radical radiotherapy in prostate cancer patients with synchronous bone oligometastasis | Chiara Lucrezia Deantoni | ![]() |
![]() |
|||
EP-1320 | Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer: Trial in progress. | Antonio Jose Conde-Moreno | ![]() |
![]() |
|||
EP-1321 | Salvage Radiotherapy in locoregional macroscopically relapsed Prostate cancer:retrospective analysis | Alessio Bruni | ![]() |
![]() |
|||
EP-1322 | PERFORMANCE DIAGNOSIS OF 11C-choline PET/CT IN PROSTATE CANCER | Pilar Maria Samper Ots | ![]() |
![]() |
|||
EP-1323 | Role of 68Ga-PSMA PET/CT in radiotherapy for prostate cancer: A single centre experience | Nina-Sophie Hegemann | ![]() |
![]() |
|||
EP-1324 | Single-fraction HDR brachytherapy boost in combination to EBRT for prostate cancer | Andres HUERTAS | ![]() |
![]() |
|||
EP-1325 | Risk adapted dose-intensified postoperative radiation therapy in prostate cancer patients using a simultaneous integrated boost technique applied with helical Tomotherapy. | Marcus Beck | ![]() |
![]() |
|||
EP-1326 | Long term patients clinical outcome after salvage post-prostatectomy Radiation Therapy (RT) | ELISABETTA GARIBALDI | ![]() |
![]() |
|||
EP-1327 | Decision Support System to implant a rectum spacer during prostate cancer radiotherapy | Yvonka van Wijk | ![]() |
![]() |
|||
EP-1330 | PREDICTIVE FACTORS FOR URINARY TOXICITY IN PATIENTS TREATED WITH RADICAL EBRT FOR PROSTATE CANCER | Carla Pisani | ![]() |
![]() |
|||
EP-1331 | EFFICACY AND SAFETY OF RE-IRRADIATION OF LOCALLY RECURRENT PROSTATE CANCER WITH FFF-VMAT | Giuseppe Roberto DAgostino | ![]() |
![]() |
|||
EP-1332 | Contouring variability with CT and MRI of prostate cancer for radiation planning | ANA OTERO-ROMERO | ![]() |
![]() |
|||
EP-1333 | Impact of 18F-Choline PET scan acquisition time on delineation of GTV in Prostate cancer | Craig Parkinson | ![]() |
![]() |
|||
EP-1334 | STEREOTACTIC RADIOTHERAPY WITH CYBERKNIFE SYSTEM IN LOCALIZED PROSTATE CANCER | Valentina Borzillo | ![]() |
![]() |
|||
EP-1335 | Hypofractionated versus conventional radiotherapy in intermediate- to high-risk prostate cancer | Wei Guo | ![]() |
![]() |
|||
EP-1336 | EFFECT OF BLADDER,TRIGONE,URETHRA DOSES ON ACUTE GENITOURINARY TOXICITY IN PROSTATE CANCER TREATMENT | MELTEM KIRLI | ![]() |
![]() |
|||
EP-1337 | HIGH PRECISION RADIOTHERAPY WITH BEACON TRANSPONDERS IN INTERMEDIATE-RISK PROSTATE CANCER: PRELIMINARY RESULTS OF TOXICITY AND EFFICACY | Lucia Di Brina | ![]() |
![]() |
|||
EP-1338 | High precision radiotherapy for early prostate cancer with concomitant boost to the dominant lesion. | Giulia Riva | ![]() |
![]() |
|||
EP-1340 | Comparing dosimetry and toxicity of 5-field IMRT versus VMAT for prostate & pelvic nodal irradiation | Philip Turner | ![]() |
![]() |
|||
EP-1341 | PELVIC SABR WITH HDR BOOST IN INTERMEDIATE AND HIGH RISK PROSTATE CANCER (SPARE):Early Results | Hima Musunuru | ![]() |
![]() |
|||
EP-1342 | Salvage stereotactic body radiotherapy for lymph node oligorecurrent prostate cancer | Giuseppe Fanetti | ![]() |
![]() |
|||
EP-1343 | IS STEREOTACTIC BODY RADIATION THERAPY A VIABLE OPTION FOR ELDERLY PATIENTS WITH PROSTATE CANCER? | Ciro Franzese | ![]() |
![]() |
|||
EP-1344 | Long-term quality of life after high-dose-rate brachytherapy boost for prostate cancer | Wendy Busser | ![]() |
![]() |
|||
EP-1345 | Dosimetric effect of seed-based prostate localisation on Pelvic Lymph Nodes in High-Risk Prostate Ca | Ronan Valentine | ![]() |
![]() |
|||
EP-1346 | Oligorecurrent nodal prostate cancer: long-term results of an elective nodal irradiation approach | Sebastien Tran | ![]() |
![]() |
|||
EP-1347 | Treatment outcomes with hypofractionated high-dose radiation therapy for prostate cancer | Daniele Candini | ![]() |
![]() |
|||
EP-1348 | Set-up errors in prostate cancer radiotherapy based on cone-beam computed tomography. | Marianna Trignani | ![]() |
![]() |
|||
EP-1349 | Adjuvant hypofractionated radiotherapy for prostate cancer: acute toxicity | Simonetta Saldi | ![]() |
![]() |
|||
EP-1350 | STEREOTACTIC RE-IRRADIATION FOR PROSTATE CANCER RECURRENCE AFTER UPFRONT SURGERY AND RADIOTHERAPY | Vanessa Di Cataldo | ![]() |
![]() |
|||
EP-1351 | STEREOTACTIC RADIOTHERAPY IN RECURRENT PROSTATE CANCER PREVIOUSLY TREATED BY RADICAL IRRADIATION | Mauro Loi | ![]() |
![]() |
|||
EP-1352 | SINGLE-FRACTION STEREOTACTIC BODY RADIOTHERAPY FOR NODAL OLIGORECURRENT PROSTATE CANCER | Mauro Loi | ![]() |
![]() |
|||
EP-1353 | Salvage hypofractionated radiotherapy for prostate cancer: acute toxicity | Simonetta Saldi | ![]() |
![]() |
|||
EP-1354 | Delayed Salvage Radiotherapy for Macroscopic Local Recurrence after Radical Prostatectomy | Mohamed Shelan | ![]() |
![]() |
|||
EP-1355 | Comparing toxicity in IMRT and particle therapy of prostate cancer in a ROCOCO in silico trial | Yvonka van Wijk | ![]() |
![]() |
|||
EP-1356 | Benefits of using stereotactic radiotherapy in patients with metachronous oligometastatic prostate cancer detected by 18Ffluoromethylcholine PET/CT | Esther Bouman-Wammes | ![]() |
![]() |
|||
EP-1357 | MODERATE HYPOFRACTIONATED-IMRT OF PROSTATE BED AFTER RADICAL PROSTATECTOM : ACUTE TOXICITY | Jeannette Valero Albarran | ![]() |
![]() |
|||
EP-1358 | Prostate postoperative hypofractionated radiotherapy: a single institution experience with Tomo | Sara Gomellini | ![]() |
![]() |
|||
EP-1359 | Pain response in a Population-based study of Radium-223 for Metastatic Prostate Cancer | Scott Tyldesley | ![]() |
![]() |
|||
EP-1360 | Stereotactic body radiotherapy for oligometastatic prostate cancer recurrence after local treatment. | Pierre-Antoine Laurent | ![]() |
![]() |
|||
EP-1362 | Correlations between dose to small intestine and bladder volume in patients receiving pelvic IMRT | Mohammad Alfayez | ![]() |
![]() |
|||
EP-1363 | Clinical efficacy of dose escalated and hypofractionated pelvic IMRT in prostate cancer | Atia Khan | ![]() |
![]() |
|||
EP-1364 | Substratification of prostate cancer risk groups by core involvement and T stage may alter prognosis | Austin Hopper | ![]() |
![]() |
|||
EP-1365 | Pure Hypofractionated Radiotherapy for the Treatment of Low- to Intermediate-Risk Prostate Cancer | Robert Stephens | ![]() |
![]() |
|||
EP-1366 | Radiotherapy aimed at functional preservation in patients with small cell carcinoma of the bladder. | Hiroko Akamatsu | ![]() |
![]() |
|||
EP-1367 | Conservation treatment of Carcinoma Penis with surface mould brachytherapy | Milan Anjanappa | ![]() |
![]() |
|||
EP-1368 | Impact of post-operative Radiotherapy in bladder cancer after loco-regional relapse. | MARIA JESUS MAÑAS | ![]() |
![]() |
|||
EP-1369 | Cystectomy with adjuvant radiotherapy for invasive bladder tumors: early results of a phase II study | Martijn Swimberghe | ![]() |
![]() |
|||
EP-1370 | Simultaneous integrated tumour boost planning in bladder cancer: a comparison of strategies | Shaista Hafeez | ![]() |
![]() |
|||
EP-1371 | Primary oesophageal melanoma responds to hypofractionated radiotherapy | Olly Donnelly | ![]() |
![]() |
|||
EP-1372 | PRELIMINAR RESULTS OF FRACTIONATED CYBERKNIFE STEREOTACTIC RADIOTHERAPY FOR UVEAL MELANOMA. | Isa Bossi Zanetti | ![]() |
![]() |
|||
EP-1374 | HYPOFRACTIONATED RADIOTHERAPY IN NON-MELANOMA SKIN CANCER = 3 CM IN ELDERLY PTS . | Letizia Ferella | ![]() |
![]() |
|||
EP-1375 | Volumetric-modulated-arc-therapy versus 3D-conformal-radiotherapy for sarcoma of extremities | Anna Maria Ascolese | ![]() |
![]() |
|||
EP-1376 | IOERT combined with EBRT in R1-resected soft tissue sarcomas of the extremities: a pooled analysis | Falk Roeder | ![]() |
![]() |
|||
EP-1377 | Single institutional experience of the treatment of angiosarcoma of the scalp | Hiroki Ihara | ![]() |
![]() |
|||
EP-1378 | Radiotherapy for the Treatment of Intracranial Solitary Fibrous Tumorn Therapy in the Treatment of Hemangiopericytoma/ Solitary Fibrous Tumo | Yin-Yin Chiang | ![]() |
![]() |
|||
EP-1379 | Heart volume reduction in paediatric cancer patients during radiotherapy | Irma van Dijk | ![]() |
![]() |
|||
EP-1380 | Impact of radiobiological models on medical decision making to individualize proton and photon radiotherapy | Abdulhamid Chaikh | ![]() |
![]() |
|||
EP-1381 | Treatment outcomes of proton craniospinal irradiation for paediatric medulloblastoma | Evangeline Ho | ![]() |
![]() |
|||
EP-1382 | Feasibility of Proton therapy with concomitant Chemotherapy for atypical teratoid rhabdoid tumors | Sarah PETERS | ![]() |
![]() |
|||
EP-1383 | Evaluation of QOL and psychological response in patients treated with palliative radiotherapy | Takeo Takahashi | ![]() |
![]() |
|||
EP-1384 | Concomitant Use of Steroids and Immunotherapy in Cancer Patients: A Comprehensive Review | Aurelie Garant | ![]() |
![]() |
|||
EP-1385 | Evaluation of the Spinal Instability Neoplastic Score for spinal metastases | Laurens Bollen | ![]() |
![]() |
|||
EP-1386 | Mobile health technologies for severely-ill and palliative care patients | Gudrun Theile | ![]() |
![]() |
|||
EP-1387 | Time Trends In Opioid Use In Cancer Patients with Pain: Observations from Administrative Data | Lisa Barbera | ![]() |
![]() |
|||
EP-1388 | Clinical features of bone metastases and their importance for radiotherapy | Natalya Bychkova | ![]() |
![]() |
|||
EP-1389 | Superficial hyperthermia with radiotherapy: toxicity and outcome of 62 metastatic lesions | Gabriella Cattari | ![]() |
![]() |
|||
EP-1390 | Superior target delineation for stereotactic body radiotherapy of bone metastases from renal cell carcinoma on MRI compared to CT | Fieke Prins | ![]() |
![]() |
|||
EP-1391 | Digestive toxicity after conformal radiotherapy for palliative cervico-thoracic spinal metastases | Guillaume Peyraga | ![]() |
![]() |
|||
EP-1392 | Prognostic factors for survival in patients with bone metastases | Pilar Maria Samper Ots | ![]() |
![]() |
|||
EP-1393 | Prognostic factors for survival in patients with brain metastases | Pilar Maria Samper Ots | ![]() |
![]() |
|||
EP-1394 | Prognostic factor for palliative radiotherapy of bone metastases in good performance-status patients | Yasushi Hamamoto | ![]() |
![]() |
|||
EP-1395 | CyberKnife treatment of intraorbital metastases: a single center experience on 24 lesions. | Giulia Riva | ![]() |
![]() |
|||
EP-1396 | VERSATIS AND FOCAL NEUROPATHIC PAIN IN CANCER PATIENTS (SCREENING TOOL) | Cristina Prieto Prieto | ![]() |
![]() |
|||
EP-1397 | Dose painting guided by diffusion-weighted MRI applied to recurrent glioblastoma: a phase I protocol | Mauro Iori | ![]() |
![]() |
|||
EP-1398 | APPLICATION OF RADIOSURGERY IN TREATMENT OF OLIGOMETASTASES | Tetiana Chebotarova | ![]() |
![]() |
|||
EP-1399 | Rotary-Dual Total Skin Electron Beam Therapy as palliative treatment for mycosis fungoides | Agata Jodda | ![]() |
![]() |
|||
EP-1400 | Quality of Life in Responders after Palliative Radiation Therapy for Painful Bone Metastases | Gustavo Marta | ![]() |
![]() |
|||
EP-1401 | SBRT for solitary extracranial metastases from gynecologic malignancies | Michael Repka | ![]() |
![]() |
|||
EP-1402 | Impact of SBRT on pain and local control for bone metastases: a systematic review and meta-analysis | Joanne van der Velden | ![]() |
![]() |
|||
EP-1403 | A comparison between 3D and volumetric technique in lumbar vertebral palliative irradiation | Nicola Ricottone | ![]() |
![]() |
|||
EP-1404 | Survival time following palliative whole brain radiotherapy to treat brain metastases | Astrid Billfalk Kelly | ![]() |
![]() |
|||
EP-1406 | Improvement in cancer pain management: the value of a joint approach in a single prospective series | Valeria Masiello | ![]() |
![]() |
|||
EP-1407 | Are future radiation oncologists equipped with the knowledge to manage elderly patients with cancer? | Niluja Thiruthaneeswaran | ![]() |
![]() |
|||
EP-1408 | Nutritional parameters in elderly patients with lung cancer and radiation treatment | JOSE LUIS MONROY ANTON | ![]() |
![]() |
|||
EP-1409 | Prospective study of hypofractionated radiotherapy for elderly patients with High Grade Glioma | Elena Clerici | ![]() |
![]() |
|||
EP-1410 | Role of PMRT in Elderly Patients with T1-2 and 1 to 3 Positive Nodes Breast Cancer | Lu Cao | ![]() |
![]() |
|||
EP-1411 | Chemo-IMRT in elderly head and neck cancer patients | Imtiaz Ahmed | ![]() |
![]() |
|||
EP-1412 | Quality of life of patients after high dose radiation therapy for thoracic carcinomas | Christina Schrder | ![]() |
![]() |
|||
EP-1413 | IORT for treatment of recurrent tumors - A single institution analysis. | Ricardo Cesar Fogaroli | ![]() |
![]() |
|||
EP-1414 | Toxicity of concurrent stereotactic radiotherapy and targeted or immunotherapy: a systematic review | Stephanie Kroeze | ![]() |
![]() |
|||
EP-1415 | Interventions to Address Sexual Problems in People with Cancer | Lisa Barbera | ![]() |
![]() |
|||
EP-1416 | A new model of care to improve clinical trial participation in radiation oncology | Shalini Vinod | ![]() |
![]() |
|||
EP-1417 | Clinical evaluation of a fully automatic body delineation algorithm for radiotherapy | Tobias Fechter | ![]() |
![]() |
|||
EP-1418 | RandOmized Study Exploring the combination of radioTherapy with Two types of Acupuncture treatment | Rebecca Asadpour | ![]() |
![]() |
|||
EP-1419 | Optimal design and patient ion for interventional trials using radiogenomic biomarkers | Dirk De Ruysscher | ![]() |
![]() |
|||
EP-1420 | Effects of Japanese traditional Kampo medicines Goreisan for acute radiation enteritis | Taiju Shimbo | ![]() |
![]() |
|||
EP-1421 | Outcome by prognostic factors of AVM treated with LINAC:18 years experience, Spanish Institution | Sergio Cafiero | ![]() |
![]() |
|||
EP-1422 | Pregnancy outcomes in cancer patients received radiotherapy: a nationwide population-based study | Yu-Jung Chiang | ![]() |
![]() |
|||
EP-1423 | THE EVALUATION OF SLEEP QUALITY IN CANCER PATIENTS FOLLOWING THE DIAGNOSIS OF A METASTATIC SITE | Eda Yirmibesoglu Erkal | ![]() |
![]() |
|||
EP-1425 | Permit to enter no-fly-zone: Risk-adapted mediastinal SBRT for oligometastases safe and effective | Daniel Holyoake | ![]() |
![]() |
|||
EP-1426 | A model for internal target volume definition based on 4D-cone beam computed tomography. | Monica Di Tommaso | ![]() |
![]() |
|||
EP-1427 | Peer reviewed radiation treatment planning process at a university hospital in a developing country | Bilal Mazhar Qureshi | ![]() |
![]() |
|||
EP-1428 | Stereotactic body radiotherapy for isolated metastasis from different primitive tumors | Andrea Lancia | ![]() |
![]() |
|||
EP-1429 | Maintaining efficacy of low-dose radiotherapy on pain and function in degenerative skeletal diseases | Beatriz Álvarez Rodríguez | ![]() |
![]() |
|||
EP-1430 | Venous thromboembolism in radiation oncology: retrospective trial | Mikhail Cherkashin | ![]() |
![]() |
|||
EP-1431 | Acute toxicity in deep loco-regional hyperthermia | Ewa Burchardt | ![]() |
![]() |
|||
EP-1432 | ADVANTAGE OF BUTTERFLY-VMAT VERSUS VMAT IN MEDIASTINAL TUMORS | Amaia Ilundain | ![]() |
![]() |
|||
EP-1433 | Photoneutron Flux Measurement via NAA in a Radiotherapy Bunker with an 18 MV Linear Accelerator | TUGCE GULUMSER | ![]() |
![]() |
|||
EP-1435 | Evaluation of single material and multi-material patient-specific, 3D-printed radiotherapy phantoms | Daniel Craft | ![]() |
![]() |
|||
EP-1436 | A newly designed water-equivalent bolus technique enables BNCT application to skin tumor. | Katsumi Hirose | ![]() |
![]() |
|||
EP-1437 | New Cobalt-60 system for reference irradiations and calibrations | Claus Andersen | ![]() |
![]() |
|||
EP-1438 | Experimental determination of correction factors for reference dosimetry in Gamma Knife Perfexion | Emmanouil Zoros | ![]() |
![]() |
|||
EP-1440 | Monte Carlo determination of scintillator quenching effect for small radiation fields | Grichar Valdes Santurio | ![]() |
![]() |
|||
EP-1441 | Repurposing of a small clinical x-ray source for radiobiology irradiations | Joerg Lehmann | ![]() |
![]() |
|||
EP-1442 | Fricke and Polymer Gel dosimeters for SRS/SBRT pre-treatment 3D dosimetry | Giulia Maria Liosi | ![]() |
![]() |
|||
EP-1443 | Measurement of 3D dose distributions from an MR Linac with gel dosimetry | Yvonne Roed | ![]() |
![]() |
|||
EP-1444 | Reliable error detection in radiochromic film dosimetry with optimal density curves and corrections | Hae-Jin Park | ![]() |
![]() |
|||
EP-1445 | Performance evaluation of scintillators for SiPM PET/MRI Brain Imaging | Natalia Campos Rivera | ![]() |
![]() |
|||
EP-1446 | Can parallel plate ion chambers be used for PDD measurements in FFF beams? | Francisco Cutanda | ![]() |
![]() |
|||
EP-1448 | Epid-based in vivo dosimetry for SBRT-VMAT treatment dose verification | Savino Cilla | ![]() |
![]() |
|||
EP-1449 | The effect of a build-up screen on superficial dose in total body irradiation | Lotte Fog | ![]() |
![]() |
|||
EP-1450 | Implementation of dosimetry equipment and phantoms in clinical practice of light ion beam therapy. | Loic Grevillot | ![]() |
![]() |
|||
EP-1451 | Validation of local tolerances for VMAT patient specific QA using the IBA Compass system | Elizabeth Crees | ![]() |
![]() |
|||
EP-1452 | Evaluation of a collapsed-cone algorithm in a commercial software for in vivo volumetric dosimetry | Jose Gimeno Olmos | ![]() |
![]() |
|||
EP-1453 | Modeling a carbon fiber couch in a commercial Treatment Planning System | Roberto Gómez Pardos | ![]() |
![]() |
|||
EP-1454 | Comparison of Treatment Planning Algorithms and Monte Carlo Simulations in Oesophageal Radiotherapy | Dewi Johns | ![]() |
![]() |
|||
EP-1455 | IGRT kV-CBCT dose calculations using Virtual Source Models and validated in phantoms using OSL | Guillaume Boissonnat | ![]() |
![]() |
|||
EP-1456 | In-vivo dosimetry using Dosimetry Check: 5-year experience on 345 prostate cancer patients | William Nailon | ![]() |
![]() |
|||
EP-1457 | Introducing the fraction of penumbra dose in the evaluation of VMAT treatment plans | Anna Bck | ![]() |
![]() |
|||
EP-1458 | 3D dose reconstruction on CBCT for daily monitoring of delivered patient dose | Karsten Eilertsen | ![]() |
![]() |
|||
EP-1459 | Relative Signal Ratios using an unshielded silicon detector: data from 30 centers | Cinzia Talamonti | ![]() |
![]() |
|||
EP-1460 | Detection of forced errors in VMAT plans using EPID and Epiqa dosimetric system | Domingo Granero | ![]() |
![]() |
|||
EP-1461 | Scintillator dosimetry reveals lung tumor size dependency of 6 MV AAA dose calculations | Patrik Sibolt | ![]() |
![]() |
|||
EP-1462 | The impact on VMAT optimization using Type C vs B algorithms for patients with temporary gas pockets | Bob Smulders | ![]() |
![]() |
|||
EP-1463 | MONET: an accurate model for the evaluation of the ion dose in water | Alessia Embriaco | ![]() |
![]() |
|||
EP-1464 | Investigation on beam width tolerances for proton pencil beam scanning | Benjamin Ackermann | ![]() |
![]() |
|||
EP-1466 | Implementation of a linac head-mounted matrix detector to clinical use for dynamic technique | Lukasz Szczurek | ![]() |
![]() |
|||
EP-1467 | IPEM Code of Practice for proton and ion beam dosimetry: update on work in progress | Stuart Green | ![]() |
![]() |
|||
EP-1468 | SKIN DOSE IN RADIOTHERAPY: RESULTS OF IN VIVO MEASUREMENTS WITH GAFCHROMIC EBT3 FILMS | Alessia Giuliano | ![]() |
![]() |
|||
EP-1469 | Flattening filter free beam profile analysis using two different normalization methods | Giorgia Nicolini | ![]() |
![]() |
|||
EP-1470 | Dose response of ferrous gels in a low energy beam produced by a mini - accelerator | Yassir Ben Ahmed | ![]() |
![]() |
|||
EP-1471 | Comparison of the integral dose of IMRT, RapidArc and helical tomotherapy prostate treatments | Jaime Martinez Ortega | ![]() |
![]() |
|||
EP-1472 | DOSIMETRIC END-TO-END VERIFICATION USING 3D PRINTING AND 3D DOSIMETER FOR BRAIN STEREOTACTIC RADIOTHERAPY | Min Su Kim | ![]() |
![]() |
|||
EP-1473 | Improving the accuracy of dosimetry verification by non-uniform backscatter correction in the EPID | Yasmin Md Radzi | ![]() |
![]() |
|||
EP-1474 | Feasibility of dose delivery error detection by a transmission detector for patient-specific QA | Hirofumi Honda | ![]() |
![]() |
|||
EP-1477 | Evaluating gamma-index quality assurance methods for Nasopharynx Volumetric Arc Therapy (VMAT) | David Thwaites | ![]() |
![]() |
|||
EP-1479 | Gamma 3D analysis for VMAT treatments using two detector arrays | EVA MARIA AMBROA REY | ![]() |
![]() |
|||
EP-1480 | Patient-specific QA for CyberKnife MLC plans using Monte Carlo | Paul-Henry Mackeprang | ![]() |
![]() |
|||
EP-1481 | Testing algorithms in water and heterogeneous medium using experimental designs | Stephane Dufreneix | ![]() |
![]() |
|||
EP-1482 | Signal Prediction for an On-line Delivery Verification System | Robert Heaton | ![]() |
![]() |
|||
EP-1483 | Pre-Treatment QA of MLC plans on a CyberKnife M6 using a liquid ion chamber array. | Laura Masi | ![]() |
![]() |
|||
EP-1484 | VALIDATION OF PTWS DIAMOND AS ALTERNATIVE METHOD FOR THE IMRT-VMAT PRETREATMENT VERIFICATION | Abel Niebla Piñero | ![]() |
![]() |
|||
EP-1485 | Dosimetric characterization of an high definition MLC for stereotactic radiotherapy treatments. | Federica Rosica | ![]() |
![]() |
|||
EP-1486 | Further developments of two complexity metrics to consider clinical aspects of VMAT treatment plans | Julia Gtstedt | ![]() |
![]() |
|||
EP-1487 | Dosimetric aspects in the development of a crawl positioning device for prone breast radiotherapy | Leen Paelinck | ![]() |
![]() |
|||
EP-1488 | Evaluation of the Efficacy and Accuracy of Customized bolus by using a 3-dimensional printer | woo keun choi | ![]() |
![]() |
|||
EP-1489 | EFFECT OF THE THERMOPLASTIC MASK ON PATIENT SKIN DOSE IN TOMOTHERAPY | Alessia Giuliano | ![]() |
![]() |
|||
EP-1490 | A 3-class density method to monitor doses to the parotid glands and spinal cord in oropharynx IMRT | Nicolas Perichon | ![]() |
![]() |
|||
EP-1491 | Verification of FFF VMAT plans with PDIP and GLAaS algorithms by using the new imager of TrueBeamSTx | TULAY ERCAN | ![]() |
![]() |
|||
EP-1492 | Influence of induced accelerator errors on dosimetric verification result and DVH of treatment plan | Marta Kruszyna-Mochalska | ![]() |
![]() |
|||
EP-1493 | Machine record parameters or Epid based data for ART QA. A comparison of two scenarios. | Peter Haering | ![]() |
![]() |
|||
EP-1494 | The MedAustron proton gantry: nozzle design recommendations based on Monte Carlo simulations | Hermann Fuchs | ![]() |
![]() |
|||
EP-1495 | Should we use correction factors for skin dose measurements with radiochromic films? | Pablo Carrasco de Fez | ![]() |
![]() |
|||
EP-1496 | A portal dosimetry dose prediction method based on CT images of Electronical Portal Imaging Device | Jaime Martinez Ortega | ![]() |
![]() |
|||
EP-1497 | Dosimetric effect of the Elekta Fraxion cranial immobilization system and dose calculation accuracy | Carlos Ferrer | ![]() |
![]() |
|||
EP-1498 | IMRT and VMAT commissioning for Versa HD linear accelerator using AAPM TG-119 | Seema Sharma | ![]() |
![]() |
|||
EP-1499 | Additional dose of Image Guided Radiation Therapy in Pediatric Patients | Joanna Topczewska-Bruns | ![]() |
![]() |
|||
EP-1501 | Field-by-field and composite plan pseudo-3D verification of IMRT techniques with radiochromic film | Tereza Hanušová | ![]() |
![]() |
|||
EP-1502 | Dosimetric assessment of brass bolus using radiochromic film | Peta Lonski | ![]() |
![]() |
|||
EP-1503 | The effect of tandem-ovoid applicator on the dose distribution in GYN brachytherapy using Ir-192 | Mohammad Hosain Sadeghi | ![]() |
![]() |
|||
EP-1504 | Monte Carlo modeling of a proton fixed beam line featuring non-isocentric PBS treatments capabilities | Alessio Elia | ![]() |
![]() |
|||
EP-1505 | Use of Portal dosimetry to monitor treatment consistency throughout the course of treatment | Sudesh Deshpande | ![]() |
![]() |
|||
EP-1506 | Temperature dependent dose readout of Gafchromic EBT3 and EBT-XD film and clinical relevance in SRT | Konrad Buchauer | ![]() |
![]() |
|||
EP-1507 | Comparison of Pencil Beam Convolution and Analytical Anisotropic algorithms for lung cancer | pinelopi gkogkou | ![]() |
![]() |
|||
EP-1508 | Quantification of skin dose and photon beam attenuation for the iBEAM couch and Compact accelerator | Mohammad Amin Mosleh-Shirazi | ![]() |
![]() |
|||
EP-1509 | Small fields defined by jaw or MLC: evaluation of MU estimation by AAA and Acuros algorithms | Giacomo Reggiori | ![]() |
![]() |
|||
EP-1511 | Radiation Dose from Megavoltage Cone Beam Computed Tomography for IGRT | ESIL KARA | ![]() |
![]() |
|||
EP-1512 | Comparison between dose transmission detector and 3d dosimetry for lung SBRT treatments. | Francesca Giglioli | ![]() |
![]() |
|||
EP-1513 | CyberKnife robotic radiotherapy delivery quality assurance using CrystalBall 3D Dosimetry System | Belal Moftah | ![]() |
![]() |
|||
EP-1514 | Planar kV imaging dose reduction study for Varian iX and TrueBeam linacs | Eduard Gershkevitsh | ![]() |
![]() |
|||
EP-1515 | A novel attachment system for cutouts in kilovoltage x-ray beam therapy | Michael Baumgartl | ![]() |
![]() |
|||
EP-1516 | Impact of lateral electrons transport modeling in radiotherapy on the prediction of secondary cancer risk for pediatric cranio-spinal irradiation patients | Abdulhamid Chaikh | ![]() |
![]() |
|||
EP-1517 | Analysis of radiotherapy risk profile applied to the patient positioning | Gisela Menegussi | ![]() |
![]() |
|||
EP-1519 | Implementation of a hybrid superfast Monte Carlo-Pencil beam dose optimizer for proton therapy | Ana Maria Barragan Montero | ![]() |
![]() |
|||
EP-1520 | Stereotactic body radiation therapy treatment planning using target volume partitioning | James Robar | ![]() |
![]() |
|||
EP-1524 | Automated treatment planning for breast and locoregional lymph nodes using Hybrid RapidArc | Marit van Duren - Koopman | ![]() |
![]() |
|||
EP-1525 | Automatic treatment plan generation for Prostate Cancer | Sren Agergaard | ![]() |
![]() |
|||
EP-1526 | Analysis of dose deposition in lung lesions: a modified PTV for a more robust optimization | Angelo Filippo Monti | ![]() |
![]() |
|||
EP-1527 | Pelvic Intensity-Modulated Radiotherapy in prone and supine position in gynaecological cancer | Elisabetta Perrucci | ![]() |
![]() |
|||
EP-1528 | RapidPlan Head and Neck model: the objectives and possible clinical benefits | Luca Cozzi | ![]() |
![]() |
|||
EP-1529 | Reducing total Monitor Units in RapidArc plans for prostate cancer | Kris Armoogum | ![]() |
![]() |
|||
EP-1530 | Validation of RayStation Fallback Planning dose-mimicking algorithm | Laurent Bartolucci | ![]() |
![]() |
|||
EP-1531 | Collimator angle influence on dose coverage for VMAT SRS treatment of four brain metastases | Carlos Ferrer | ![]() |
![]() |
|||
EP-1532 | ITV optimization for SBRT lung treatment planning accounting for respiratory dose blurring | Carla Casadevall-Cases | ![]() |
![]() |
|||
EP-1533 | Modulation complexity assessment in VMAT plans from different treatment planning systems. | Peter Winkler | ![]() |
![]() |
|||
EP-1535 | knowledge based planning for lung cancer patients with stereotactic ablative radiotherapy | Suzanne Smith | ![]() |
![]() |
|||
EP-1536 | The advantages of Collimator Optimization for Intensity Modulated Radiation Therapy | Silvia Pella | ![]() |
![]() |
|||
EP-1538 | VMAT craniospinal radiotherapy, planning strategy and results in twenty pediatric and adult patients | Franoise Lliso | ![]() |
![]() |
|||
EP-1540 | Optimal fractionation schemes for radiosurgery of large brain metastases | Jan Unkelbach | ![]() |
![]() |
|||
EP-1541 | 4D dose reconstruction using common treatment planning systems in combination with a respiratory motion model | Christoph Bert | ![]() |
![]() |
|||
EP-1543 | Dominant intraprostatic lesions boosting: comparison of tomotherapy, VMAT and IMPT | Piotr Andrzejewski | ![]() |
![]() |
|||
EP-1544 | Predicting patient specific toxicity levels to guide radiotherapy treatment ion | Jim Tol | ![]() |
![]() |
|||
EP-1545 | Mixed photon-electron radiation therapy optimisation using the column generation method | Renaud Marc-Andre | ![]() |
![]() |
|||
EP-1546 | MR-Linac based single fraction ablative radiotherapy for early-stage breast cancer: a planning study | Ramona Charaghvandi | ![]() |
![]() |
|||
EP-1547 | Optimal treatment planning for H&N: evaluation of a predict parotid glands sparing tool | Nolwenn DELABY | ![]() |
![]() |
|||
EP-1548 | Dose to risk organs in deep inspiration breath hold non-coplanar VMAT for lung cancer radiotherapy | Mirjana Josipovic | ![]() |
![]() |
|||
EP-1549 | Cyberknife Iris based versus InCise based plans for 20 cases of prostate oligonodal metastases | Cheng Lee Chaw | ![]() |
![]() |
|||
EP-1550 | Investigating the advantages of CyberKnife M6 MLC over Iris collimator for Liver SBRT plans | Laura Masi | ![]() |
![]() |
|||
EP-1551 | Radiobiological optimization and plan evaluation in IMRT planning of prostate cancer | Stefania Cora | ![]() |
![]() |
|||
EP-1552 | Robust optimization for IMPT of pencil-beam scanning proton therapy for prostate cancer | Charlotte Brouwer | ![]() |
![]() |
|||
EP-1553 | Dose reduction of femoral heads using volumetric-modulated Dynamic WaveArc for prostate cancer | Kiyonao Nakamura | ![]() |
![]() |
|||
EP-1554 | Partially ablative VMAT for large tumors using simultaneous integrated boost: a proof of concept | Savino Cilla | ![]() |
![]() |
|||
EP-1555 | Improving inter-planner variability in head and neck (H&N) VMAT | Hayley James | ![]() |
![]() |
|||
EP-1556 | Dosimetric commissioning of a TPS for a synchrotron-based proton PBS delivery system | Gabriele Kragl | ![]() |
![]() |
|||
EP-1557 | Minimum prescription concept for dose painting increases robustness towards geometrical uncertainty | Stine Korreman | ![]() |
![]() |
|||
EP-1558 | Dosimetric evaluation of incidental radiation of internal mammary chain in breast cancer with 3D RT | Aura Cecilia Ciafre | ![]() |
![]() |
|||
EP-1559 | Optimizing the risks for deterministic effects and secondary malignancies in bladder and rectum | Panayiotis Mavroidis | ![]() |
![]() |
|||
EP-1560 | Left breast cancer planning with VMAT technique: the dosimetric trade-offs | Antonella Fogliata | ![]() |
![]() |
|||
EP-1561 | Comparison of heart, lung doses, and skin toxicity from different breast cancer RT techniques. | MARIA LIZONDO | ![]() |
![]() |
|||
EP-1562 | A Dose Painting Study Based on CT Intratumoural Heterogeneity vs. FDG PET Uptake in NSCLC | Sheaka Alobaidli | ![]() |
![]() |
|||
EP-1563 | Treatment Planning for Synchrotron Microbeam Radiotherapy using the Eclipse TPS | Liam Day | ![]() |
![]() |
|||
EP-1564 | Dosimetric assessment of pseudo-CT based proton planning | Giampaolo Pileggi | ![]() |
![]() |
|||
EP-1565 | Best of both worlds: 3D-CRT-based VMAT for locoregional irradiation in breast cancer. | Peter van Kollenburg | ![]() |
![]() |
|||
EP-1566 | Biologically optimized IMRT plans for prostate cancer using population-based tumour biology | Emily Her | ![]() |
![]() |
|||
EP-1567 | Inverse planning versus forward planning for orbital lymphoma | EVA MARIA AMBROA REY | ![]() |
![]() |
|||
EP-1568 | Benefit of a breath hold radiotherapy technique for breast and internal mammary nodes irradiation | Fanny Jouyaux | ![]() |
![]() |
|||
EP-1569 | A comparison of SRS plan quality when using VMAT vs non-coplanar static conformal fields. | Robert Brass | ![]() |
![]() |
|||
EP-1570 | The dynamic jaw mode of tomotherapy: Better neural structure protection for advanced NPC patients? | Pen-Tzu Fang | ![]() |
![]() |
|||
EP-1571 | Radiotherapy treatments using a prototype MLC design | Paige Nitsch | ![]() |
![]() |
|||
EP-1572 | Feasibility study of prone position in radiotherapy of breast with regional lymph nodes | Ewa Pawlowska | ![]() |
![]() |
|||
EP-1573 | TBI and TMI treatment comparison using bilateral and anteroposterior delivery techniques | Emmily Sandrini | ![]() |
![]() |
|||
EP-1575 | Automated VMAT planning for whole brain irradiation with hippocampus sparing | Jerome Krayenbuehl | ![]() |
![]() |
|||
EP-1576 | Tomotherapy WBRT with SIB planning for patients with brain metastases | Dmytro Synchuk | ![]() |
![]() |
|||
EP-1577 | Hippocampus-sparing whole-brain IMRT and simultaneous integrated boost to multiple brain metastases | Savino Cilla | ![]() |
![]() |
|||
EP-1578 | Frameless intracranial radiosurgery with Helical Tomotherapy: preliminary results. | Martina Iacco | ![]() |
![]() |
|||
EP-1579 | Practical dosimetrical issues in Intraoperative electron radiation therapy | Shada Wadi-Ramahi | ![]() |
![]() |
|||
EP-1580 | Dosimetric comparison between 3D-conformal radiation therapy and VMAT in Total Lymphoid Irradiation | Carlos Ferrer | ![]() |
![]() |
|||
EP-1581 | Dosimetric comparison of treatment plans for pancreatic cancer: 3DCRT, IMRT and VMAT | Pasquale Trecca | ![]() |
![]() |
|||
EP-1582 | Analysis of Risk of a Second Cancer from Scattered Radiation in Acoustic Neuroma Treatment | Yoonjin Oh | ![]() |
![]() |
|||
EP-1583 | Quantifying Plan Quality Metrics using Conventional and Stereotactic dosimetric indices in Lung SBRT | Ravindra Yaparpalvi | ![]() |
![]() |
|||
EP-1584 | Deformable image registration and dose accumulation for arc-Total Body Irradiation | Gabriele Guidi | ![]() |
![]() |
|||
EP-1585 | A practical method to reduce monitor units in prostate cancer RapidArc plans | David Sánchez | ![]() |
![]() |
|||
EP-1586 | ART and VMATthe benefits in bone marrow sparing for patients with bladder cancer | Maria Poncyljusz | ![]() |
![]() |
|||
EP-1587 | feasibility investigation of prone position robotic radiosurgery treatment for dorsal metastasis | ESRA KUCUKMORKOC | ![]() |
![]() |
|||
EP-1590 | Can bolus range shifting improve plan quality in the IMPT of head and neck cancer? | Steven Michiels | ![]() |
![]() |
|||
EP-1591 | Evaluation of noninvasive eye fixation system on Cyberknife radiotherapy of orbitals tumors | Agnieszka Skrobala | ![]() |
![]() |
|||
EP-1592 | Biological effective dose to the heart and lungs estimated by three variable RBE models during cranio-spinal proton radiotherapy | Eivind Rrvik | ![]() |
![]() |
|||
EP-1593 | Accuracy of TCP model for nasopharyngeal cancer after more than five years average follow-up | Michele Avanzo | ![]() |
![]() |
|||
EP-1594 | Development of multivariable models for acute toxicities in nasopharyngeal cancer radiotherapy | Anna Cavallo | ![]() |
![]() |
|||
EP-1595 | NTCP models for early toxicities in patients with prostate or brain tumours receiving proton therapy | Almut Dutz | ![]() |
![]() |
|||
EP-1596 | Developing and validating a survival prediction model for NSCLC patients using distributed learning | Arthur Jochems | ![]() |
![]() |
|||
EP-1597 | Focal dose escalation in prostate cancer with PSMA-PET/CT and MRI: planning study based on histology | Constantinos Zamboglou | ![]() |
![]() |
|||
EP-1598 | Modelisation of radiation response at various fractionation from histopathological prostate tumors | Vivien Aubert | ![]() |
![]() |
|||
EP-1599 | Mathematical modeling of the synergistic combination of cancer immunotherapy and radiotherapy | Crister Ceberg | ![]() |
![]() |
|||
EP-1600 | Delta radiomics of NSCLC using weekly cone-beam CT imaging: a feasibility study | Janita van Timmeren | ![]() |
![]() |
|||
EP-1601 | Do higher CT pixel values outside the GTV predict for poorer lung cancer survival? | Marcel van Herk | ![]() |
![]() |
|||
EP-1602 | Treatment planning individualisation based on 18F-HX4 PET hypoxic subvolumes in NSCLC patients | Emely Lindblom | ![]() |
![]() |
|||
EP-1603 | Atlas of complication incidence to explore dosimetric contributions to osteoradionecrosis | Laia Humbert-Vidan | ![]() |
![]() |
|||
EP-1604 | Ion induced complex DNA damage: In silico modelling of damage and repair using Geant4-DNA. | John Warmenhoven | ![]() |
![]() |
|||
EP-1605 | Deep learning of radiomics features for survival prediction in NSCLC and Head and Neck carcinoma | Arthur Jochems | ![]() |
![]() |
|||
EP-1606 | Calculating ion-induced cell death and chromosome damage by the BIANCA biophysical model | Mario Pietro Carante | ![]() |
![]() |
|||
EP-1607 | Secondary cancer risk after particle therapy for organs distal or lateral to the target volume | Laura Toussaint | ![]() |
![]() |
|||
EP-1608 | Deriving HPV status from standard CT imaging: a radiomic approach with independent validation | Ralph Leijenaar | ![]() |
![]() |
|||
EP-1609 | Tolerance doses for detailed late effects after prostate cancer radiotherapy a post-QUANTEC review | Caroline Olsson | ![]() |
![]() |
|||
EP-1610 | Predictors for morbidity from planned vs. delivered rectal dose maps in RT of prostate cancer | Oscar Casares-Magaz | ![]() |
![]() |
|||
EP-1611 | Dose-response relationships for radiation-induced urgency syndrome after gynecological radiotherapy | Eleftheria Alevronta | ![]() |
![]() |
|||
EP-1612 | Estimates of the a/ ratio for prostate using data from recent hypofractionated RT trials. | Sarah Gulliford | ![]() |
![]() |
|||
EP-1613 | Modelling DNA damage on gold nanoparticle enhanced proton therapy | Marios Sotiropoulos | ![]() |
![]() |
|||
EP-1614 | Uncertainty of dose-volume constraints obtained from radiation pneumonitis dose-response analysis | Christina Maria Lutz | ![]() |
![]() |
|||
EP-1615 | Second cancer risk after radiation of localized prostate cancer with and without flattening filter | Marius Treutwein | ![]() |
![]() |
|||
EP-1616 | Phase II trial of a novel device for DIBH in left-sided breast cancer: preliminary results | Ingrid Romera-Martínez | ![]() |
![]() |
|||
EP-1617 | Reproducibility and stability of vmDIBHs during breast cancer treatment measured using a 3D camera | Martijn Kusters Kusters | ![]() |
![]() |
|||
EP-1618 | Can diaphragm motion function as a surrogate for motion of esophageal tumors during treatment? | Sophie Heethuis | ![]() |
![]() |
|||
EP-1619 | Determination of Lung Tumour Motion from PET Raw Data used for Accelerometer Based Motion Prediction | Gisela Hrtgen | ![]() |
![]() |
|||
EP-1620 | The immobilizing effect of the vacuum cushion in spinal SBRT and the impact of pain | Joanne van der Velden | ![]() |
![]() |
|||
EP-1621 | Intrafraction errors in cranial radiotherapy with standard VMAT mask: implications for SRS/SRT. | Fares Azoury | ![]() |
![]() |
|||
EP-1622 | Intra-fractional isocenter position analysis and dose evaluation of DIBH breast treatment using surface guided RT | Lovisa Berg | ![]() |
![]() |
|||
EP-1624 | Respiratory gating of an Elekta linac using a Microsoft Kinect v2 system | David Edmunds | ![]() |
![]() |
|||
EP-1625 | Comprehensive prospective evaluation tool for treatments of thoracic tumours with scanned protons | Cássia Ribeiro | ![]() |
![]() |
|||
EP-1626 | Predicting motion of normal tissue using incomplete real-time data during lung radiotherapy. | Louise Bendall | ![]() |
![]() |
|||
EP-1627 | Anatomical advantages of deep inspiration breath hold for breast radiotherapy: a geometric analysis | Leigh Conroy | ![]() |
![]() |
|||
EP-1628 | Analysis of prostate SBRT treatments using 3D transperineal ultrasound image guidance methods | Martin Szegedi | ![]() |
![]() |
|||
EP-1629 | Lung tumor tracking using CBCT-based respiratory motion models driven by external surrogates | Aurora Fassi | ![]() |
![]() |
|||
EP-1630 | The impact of DIBH on dose to the junction in loco-regionally treated left-sided breast patients | Marille van Hinsberg | ![]() |
![]() |
|||
EP-1631 | REPRODUCIBILITY OF DIBH TECNIQUE GUIDED BY AN OPTICAL SYSTEM: THE FLORENCE USL EXPERIENCE | Serenella Russo | ![]() |
![]() |
|||
EP-1632 | A motion monitoring and processing system based on computer vision: prototype and proof of principle | Nicolas Leduc | ![]() |
![]() |
|||
EP-1634 | Combined 4D and 3D cone beam CT protocol for lung SBRT for reliable and fast position verification | Wietske Woliner - van der Weg | ![]() |
![]() |
|||
EP-1635 | Framework for the evaluation of interplay effects between respiratory motion and dose application | Asmus von Mnchow | ![]() |
![]() |
|||
EP-1636 | Evaluation of the accuracy in frame-less image-guided radiotherapy and radiosurgery. | Martina Iacco | ![]() |
![]() |
|||
EP-1637 | Critical appraisal of deep inspiration breath hold CBCT for left breast using VMAT | pietro mancosu | ![]() |
![]() |
|||
EP-1638 | Comparison dual image registrations for SBRT treatment in central and peripheral tumour lung cancer | David Esteban | ![]() |
![]() |
|||
EP-1639 | Does intrafraction motion between vmDIBHs during breast cancer treatment impact on delivered dose? | martijn kusters | ![]() |
![]() |
|||
EP-1640 | Dosimetric consequences of PTV margin reduction in cervix cancer radiotherapy with VMAT and IGRT | Thomas Berger | ![]() |
![]() |
|||
EP-1641 | Intra-fractional CBCT validation of a 6D couch to facilitate precision RT of head and neck cancer | Anders Bertelsen | ![]() |
![]() |
|||
EP-1642 | Patient-specific transperineal ultrasound probe setups for image guided radiotherapy | Saskia Camps | ![]() |
![]() |
|||
EP-1643 | Simulate baseline shift uncertainties to improve robustness of proton therapy treatments | Kevin Souris | ![]() |
![]() |
|||
EP-1644 | Deep inspiration breath hold respiratory gated 3DRT for left breast cancer:Our clinical experience. | María Pinto | ![]() |
![]() |
|||
EP-1645 | Optimization of on-line setup verification and adaptive radiotherapy for breast cancer patients | Marion Essers | ![]() |
![]() |
|||
EP-1646 | Impact of interobserver variability and setup uncertainty on dose in organs-at-risk | Vesna Prokic | ![]() |
![]() |
|||
EP-1647 | Validation of a set up procedure for IMRT/VMAT breast treatment using in vivo dosimetry with EPID | Lucia Clara Orlandini | ![]() |
![]() |
|||
EP-1648 | Thermoplastic mask dependency with interfractional uncertainties for head and neck VMAT treatments | EVA MARIA AMBROA REY | ![]() |
![]() |
|||
EP-1649 | Comparison of two thermoplastic immobilization shells for frameless stereotactic radiotherapy | Isabelle Gagne | ![]() |
![]() |
|||
EP-1651 | Dosimetric impact of rotations correction in Stereotactic RT. How much a 6DoF couch is useful? | Silvia Chiesa | ![]() |
![]() |
|||
EP-1652 | A new position verification protocol for breast cancer with simultaneous boost | Karina Lindberg Gottlieb | ![]() |
![]() |
|||
EP-1653 | PolymarkTM fiducial markers migration in Prostate Image Guided Radiation Therapy using CBCT images | CRISTINA CAMACHO LÓPEZ | ![]() |
![]() |
|||
EP-1654 | Clinical set up and first results of EPID in vivo dosimetry in an overload Chinese Radiotherapy | Lucia Clara Orlandini | ![]() |
![]() |
|||
EP-1655 | Improved patient setup for breast cancer patients using the predicted (absolute) couch position. | Marion Essers | ![]() |
![]() |
|||
EP-1656 | The inter-fraction variation of the supraclavicular- and the axilla-area in breast cancer patients | Suzan Gerrets | ![]() |
![]() |
|||
EP-1657 | Clinical use of transit dosimetry to analyze inter-fraction motion errors | Fatemeh Ebrahimi Tazehmahalleh | ![]() |
![]() |
|||
EP-1658 | The effect of weight loss in head and neck patients in the presence of a magnetic field | Robert Chuter | ![]() |
![]() |
|||
EP-1659 | Quantitative triggering of plan adaptation: monitoring plan quality by recalculation on CBCT scans | Richard Canters | ![]() |
![]() |
|||
EP-1660 | Improvement in tumour control probability by adapting dose to daily OAR DVCs | Daniel Foley | ![]() |
![]() |
|||
EP-1661 | Adaptive strategy to accommodate anatomical changes during RT in oesophageal cancer patients | Tine Bisballe Nyeng | ![]() |
![]() |
|||
EP-1662 | Interfractional trend analysis of sinograms: a decision-making for adaptive radiotherapy | Sara Bresciani | ![]() |
![]() |
|||
EP-1663 | Automated full-online replanning of SBRT lymph node oligometastases for the MR-linac | Dennis Winkel | ![]() |
![]() |
|||
EP-1664 | Two-step verification of dose deformation in presence of large inter-fraction changes during LACC RT | Akos Gulyban | ![]() |
![]() |
|||
EP-1665 | Library of plans approach for bladder cancer radiotherapy including a simultaneous integrated boost | SAREH NAKHAEE | ![]() |
![]() |
|||
EP-1666 | Adaptive radiotherapy in prostate cancer: when and why? | Rodrigo Muelas | ![]() |
![]() |
|||
EP-1667 | MR-Guided Radiotherapy of Head and Neck Cancers: Adaptive Planning Strategies | Nesrin Dogan | ![]() |
![]() |
|||
EP-1668 | Dose calculation accuracy using CBCT images for head and neck VMAT | María Auxiliadora Carrasco Herrera | ![]() |
![]() |
|||
EP-1669 | Assessment of the clinical value of off-line adaptive strategies for tomotherapy treatments | Damien Dumont | ![]() |
![]() |
|||
EP-1670 | Couch shifts in NAL protocols: Which is the optimal threshold? | Albert Camarasa Escubedo | ![]() |
![]() |
|||
EP-1671 | Calculation of the skin dose-of- the-day during Tomotherapy for head and neck cancer patients | Martina Mori | ![]() |
![]() |
|||
EP-1672 | Dual energy CT for improved proton stopping power estimation in head and neck cancer patients | Vicki Taasti | ![]() |
![]() |
|||
EP-1673 | Electron-density assessment using dual-energy CT: accuracy and robustness | Christian Mhler | ![]() |
![]() |
|||
EP-1674 | Experimental investigation of CT imaging approaches to deal with metal artefacts in proton therapy | Marta Peroni | ![]() |
![]() |
|||
EP-1675 | Influence of CT contrast agent on head and neck VMAT dose distributions | Layal Obeid | ![]() |
![]() |
|||
EP-1676 | Comparison of accuracy of Hounsfield units obtained from pseudo-CT and true CT images | Nick Reynaert | ![]() |
![]() |
|||
EP-1677 | Multicentre initiative for standardisation of image biomarkers | Alex Zwanenburg | ![]() |
![]() |
|||
EP-1678 | Are PET radiomic features robust enough with respect to tumor delineation uncertainties? | Maria Luisa Belli | ![]() |
![]() |
|||
EP-1679 | Preliminary functional imaging study on an integrated 1.5T MR-Linac machine | Mo Kadbi | ![]() |
![]() |
|||
EP-1680 | Assessing tumour necrosis in lung cancer with dual energy CT quantitative imaging | Víctor González Pérez | ![]() |
![]() |
|||
EP-1681 | 11C-choline PET/MRI for characterization of primary high-risk prostate cancer: Correlations of PET imaging parameters with clinical features | Jing-Ren Tseng | ![]() |
![]() |
|||
EP-1682 | Comparison of SUV based on different ROIs and VOIs definitions: a multi-center 4D phantom study | marie lambrecht | ![]() |
![]() |
|||
EP-1684 | Optimal window for assessing treatment responsiveness on repeated FDG-PET scans in NSCLC patients | Marta Lazzeroni | ![]() |
![]() |
|||
EP-1685 | CT-Radiomics outperforms FMISO-PET/CT for the prediction of local control in head-and-neck cancer | Jairo Andres Socarras Fernandez | ![]() |
![]() |
|||
EP-1686 | Diffusion weighted imaging for treatment response prediction in advanced rectal cancer | Henrik Nissen | ![]() |
![]() |
|||
EP-1687 | Texture analysis of 18F-FDG PET/CT predicts local control of stage I NSCLC treated by SBRT | Kazuya Takeda | ![]() |
![]() |
|||
EP-1688 | Voxelbased analysis of FMISO-PET and diffusion-weighted MRI of two different HNSCC models in mice | René Winter | ![]() |
![]() |
|||
EP-1689 | Gleason driven dose painting based on ADC MR imaging | Eric Grnlund | ![]() |
![]() |
|||
EP-1691 | Multi-modal voxel-based correlation between DCE-CT/MRI and DWI in metastatic brain cancer | Catherine Coolens | ![]() |
![]() |
|||
EP-1692 | Multi-device textural analysis on 18F-FDG PET images for predicting cervical cancer recurrence | Sylvain Reuzé | ![]() |
![]() |
|||
EP-1693 | Functional MRI to individualize PTV margins to seminal vesicles with suspected cancer involvement | Sidsel Damkjr | ![]() |
![]() |
|||
EP-1694 | DW-MRI as a predictor of tumor response to hypofractionated stereotactic boost for prostate cancer | David PASQUIER | ![]() |
![]() |
|||
EP-1695 | Intra-treatment diffusion MRI for predicting radiotherapy response in head and neck cancer patients | Eva Samsoee | ![]() |
![]() |
|||
EP-1696 | Dose-painting planning with uncertainties in dose-response parameters and in patient positioning | Steven Petit | ![]() |
![]() |
|||
EP-1697 | Does contrast agent influence the prognostic accuracy of CT radiomics based outcome modelling? | Stephanie Tanadini-Lang | ![]() |
![]() |
|||
EP-1698 | Impact of motion and segmentation on PET texture features: evaluation with heterogeneous phantoms. | Montserrat Carles | ![]() |
![]() |
|||
EP-1699 | The simulation study of position and biology of target with PET in high energy X-Ray irradiation | quanshi zhang | ![]() |
![]() |
|||
EP-1700 | Prognostic value of FCH PET/CT in response to radical radiotherapy for localized prostate cancer | Matteo Sepulcri | ![]() |
![]() |
|||
EP-1701 | Method for FDG-PET Background Signal Definition in Rectal Adenocarcinoma Patients Using Differential Uptake Volume Histograms | James Schneider | ![]() |
![]() |
|||
EP-1702 | Evaluation of radiation induced MRI intensity change in vertebral bodies after proton beam scanning | Lorenzo Placidi | ![]() |
![]() |
|||
EP-1703 | Rapid prototyping phantom using LEGO for MRI distortion correction in MR guided radiation therapy | Sebastian Neppl | ![]() |
![]() |
|||
EP-1704 | Breast tumour bed contouring: influence of surgical clips assessed on the same imaging. | Delia Ciardo | ![]() |
![]() |
|||
EP-1706 | Validation of a novel hybrid deformable image registration algorithm for cervix cancer | Martin Buschmann | ![]() |
![]() |
|||
EP-1707 | Dose of the day in Head-Neck cancer Tomotherapy: a DIR-based methods comprehensive validation | Marco Branchini | ![]() |
![]() |
|||
EP-1708 | Investigating the reproducibility of geometric distortion measurements for MR-only radiotherapy | Jonathan Wyatt | ![]() |
![]() |
|||
EP-1709 | Can atlas-based automatic segmentation contour H&N OARs like a physician? | Nicola Maffei | ![]() |
![]() |
|||
EP-1710 | Chemical stability of BioXmark following normofractionated and single-fraction proton beam therapy | Esther Troost | ![]() |
![]() |
|||
EP-1711 | Effect of Noise Floor Suppression on Diffusion Kurtosis for Prostate Brachytherapy | Ziyafer Gizem PORTAKAL | ![]() |
![]() |
|||
EP-1712 | Quantification of radiotherapy-induced mediastinum changes using serial CT imaging | Catarina Veiga | ![]() |
![]() |
|||
EP-1713 | Feasibility of low dose 4D CBCT in patients with lung cancer. | Abigail Bryce-Atkinson | ![]() |
![]() |
|||
EP-1714 | Automatic delineation of the gross-tumour volume in prostate cancer using shape models | William Nailon | ![]() |
![]() |
|||
EP-1715 | Differences in delineation uncertainty using MR images only vs CT-MR in recurrent gynaecological GTV | David Bernstein | ![]() |
![]() |
|||
EP-1716 | Semantic PACS deployment enables research in a radiation oncology research environment | M. S. Marshall | ![]() |
![]() |
|||
EP-1717 | Image Quality Comparison Between Two Radiotherapy Simulators | Tomic Nada | ![]() |
![]() |
|||
EP-1718 | Application of motion compensation in 4D CT of oesophageal cancer. | Andrew Green | ![]() |
![]() |
|||
EP-1719 | Diagnostic DSAs, a resource for radiotherapy treatment planning of AVMs | Paul Davenport | ![]() |
![]() |
|||
EP-1720 | Framework for Statistical Cone-Beam CT Reconstruction with Prior Monte-Carlo Scatter Estimation | Jonathan Mason | ![]() |
![]() |
|||
EP-1721 | A new calibration method of an Elekta XVI (R.5.0.2) system able to achieve superior image quality. | Dominika Oborska-Kumaszynska | ![]() |
![]() |
|||
EP-1722 | Inter-observer agreement of ACR MRI phantom Test on a 1.5T MR-simulator with Flexible Coil setting | Oi Lei Wong | ![]() |
![]() |
|||
EP-1723 | Optimisation of an Elekta XVI (R.5.0.2) system for clinical protocols image quality vs dose. | Dominika Oborska-Kumaszynska | ![]() |
![]() |
|||
EP-1724 | Phantom image quality evaluation under 3 coil settings for abdominal MR-simulation at 1.5T | Oi Lei Wong | ![]() |
![]() |
|||
EP-1725 | Predicting radiation-induced pneumonitis in NSCLC: a radiobiological and texture analysis study | William Nailon | ![]() |
![]() |
|||
EP-1726 | Efficacy of vendor supplied distortion correction algorithms for a variety of MRI scanners | Eleftherios Pappas | ![]() |
![]() |
|||
EP-1728 | Inter-observer contouring similarity metrics: Correlations with treatment outcome for prostate cancer | Roach Dale | ![]() |
![]() |
|||
EP-1729 | Air pockets in the urinary bladder during hyperthermia treatment reduce thermal dose | Gerben Schooneveldt | ![]() |
![]() |
|||
EP-1731 | What can reveal onsite end-to-end audit? The experience of national dosimetry audit group | Irena Koniarová | ![]() |
![]() |
|||
EP-1732 | Treatment Planning of Dose Escalation for Anal Cancer in the PLATO Trial | Natalie Abbott | ![]() |
![]() |
|||
EP-1733 | Proton grid therapy (PGT): a parameter study | Thomas Henry | ![]() |
![]() |
|||
EP-1734 | AAPM TG-119 benchmarking of a novel jawless dual level MLC collimation system | Dimitris mihailidis | ![]() |
![]() |
|||
EP-1735 | Total skin irradiation with helical Tomotherapy: Planning and dosimetry feasibility aspects | André Haraldsson | ![]() |
![]() |
|||
EP-1736 | Radiation and lasers isocenters coincidence with ArcCheck phantom | FERNANDO TATO DE LAS CUEVAS | ![]() |
![]() |
|||
EP-1737 | Efficient troubleshooting of accelerator faults using the TrueBeam Log Viewer software application | Lars Hjorth Praestegaard | ![]() |
![]() |
|||
EP-1738 | Performance of a new EPID panel and opportunities for a fast MV-CBCT acquisition. | Christopher Kennedy | ![]() |
![]() |
|||
EP-1739 | The feasibility of atlas-based automatic segmentation of MRI for prostate radiotherapy planning | Richard Speight | ![]() |
![]() |
|||
EP-1740 | Nationwide audit of multileaf collimators performance | Krzysztof Chelminski | ![]() |
![]() |
|||
EP-1741 | Commissioning of a robotic patient positioning system equipped with an integrated tracking system | Alexander Ableitinger | ![]() |
![]() |
|||
EP-1742 | Optimisation and implementation of brain CBCT templates; an institutional pilot study. | Shabnam Petkar | ![]() |
![]() |
|||
EP-1743 | Evaluation of proton grid therapy in challenging clinical cases | Thomas Henry | ![]() |
![]() |
|||
EP-1744 | Failure modes and effects analysis of Total Skin Electron Irradiation (TSEI) technique | Blanca Ibanez-Rosello | ![]() |
![]() |
|||
EP-1745 | EPID and Gantry sag characterization in Elekta LINAC | FERNANDO TATO DE LAS CUEVAS | ![]() |
![]() |
|||
EP-1746 | A new method for exact co-calibration of the ExacTrac X-ray system and linac imaging isocenter | Hella Sand | ![]() |
![]() |
|||
EP-1747 | From pre-treatment verification towards in-vivo dosimetry in TomoTherapy | Tania Santos | ![]() |
![]() |
|||
EP-1748 | Mesorectal-only irradiation for early stage rectal cancer: Target volumes and dose to organs at risk | Ane Appelt | ![]() |
![]() |
|||
EP-1749 | The IROC QA Centers Activities Supporting the NCIs National Clinical Trial Network | David Followill | ![]() |
![]() |
|||
EP-1751 | A comparison of tools for Delivery Quality Assurance in TomoTherapy | Tania Santos | ![]() |
![]() |
|||
EP-1752 | A simple technique for an accurate shielding of the lungs during total body irradiation | Hana Mekdash | ![]() |
![]() |
|||
EP-1753 | Determining the effect of using lead as electron cutout material compared to low melting point alloy | Mark Wanklyn | ![]() |
![]() |
|||
EP-1754 | Isocentric accuracy of Elekta VersaHD linear accelerators | Mirjam Mast | ![]() |
![]() |
|||
EP-1755 | Multi-modality end-to-end audit by the ACDS | Jessica Lye | ![]() |
![]() |
|||
EP-1756 | Treatment planning and dosimetric validation of bone oligomet SABR treatments on TomoTherapy | Christopher Thomas | ![]() |
![]() |
|||
EP-1757 | QA of MLC Elekta Agility for Static fields | FERNANDO TATO DE LAS CUEVAS | ![]() |
![]() |
|||
EP-1758 | Towards Clinical Implementation of an Online Beam Monitoring System | Mohammad Islam | ![]() |
![]() |
|||
EP-1759 | MLC positioning study based on EPID images analyzed with the Dosimetry Check software | Cinzia Avigo | ![]() |
![]() |
|||
EP-1760 | A simple method for estimating the longitudinal isocentre shift due to gantry motion | Primoz Peterlin | ![]() |
![]() |
|||
EP-1763 | Acute toxicity and in-vivo dosimetry of a two week hypofractionated schedule within the HYPORT study | Animesh Saha | ![]() |
![]() |
|||
EP-1764 | Implementation of a patient specific QA in-vivo dosimetry protocol using the PerFRACTION 3D system | Filipa Vinagre | ![]() |
![]() |
|||
EP-1765 | Volume delineation based on 18FDG-PET and MRI in head and neck cancer treated with IG-VMAT | LUCIA MENDEZ | ![]() |
![]() |
|||
EP-1766 | First experiences using the new Papillon TM Contact X-Ray Brachytherapy 50KVp (CXB) for breast IORT. | GERARD Jean-Pierre | ![]() |
![]() |
|||
EP-1767 | The Dosimetric Consequences Throughout The Treatment Time In APBI With SAVI Applicators. | Shereen Chandrasekara | ![]() |
![]() |
|||
EP-1768 | What is the proper dose in single fraction HDR brachytherapy as monotherapy for prostate cancer? | Samuel Ruiz Arrebola | ![]() |
![]() |
|||
EP-1769 | Hypofractionated EBRT and single fraction HDR brachytherapy for patients with prostate cancer. | Dorota Kazberuk | ![]() |
![]() |
|||
EP-1770 | Unpredictable PSA failure in intermediate-risk prostate cancer after seed implant brachytherapy | Koyo Kikuchi | ![]() |
![]() |
|||
EP-1771 | Low dose rate brachytherapy for prostate cancer: A Brazilian Institution experience. | Gustavo Marta | ![]() |
![]() |
|||
EP-1772 | HDR Brachytherapy in the treatment of Prostate Cancer the Vienna Experience | Oxana Komina | ![]() |
![]() |
|||
EP-1773 | Clinical outcomes in localized prostate cancer treated with HDR Brachytherapy as single fraction | Luis Larrea | ![]() |
![]() |
|||
EP-1774 | Randomized phase II trial of IGRT with or without HDR boost in intermediate-risk prostate cancer | Eric Vigneault | ![]() |
![]() |
|||
EP-1775 | ACUTE TOXICITY IN EARLY CANCER PROSTATE PATIENTS: LOW DOSE RATE VS HIGH DOSE RATE MONOTHERAPY. | SILVIA RODRIGUEZ VILLALBA | ![]() |
![]() |
|||
EP-1776 | Is a single CT plan for vaginal cylinder brachytherapy adequate? | Mark Zahra | ![]() |
![]() |
|||
EP-1777 | Cervical cancer outcomes in the high-dose-rate brachytherapy era: A single institution experience | Najlaa Alyamani | ![]() |
![]() |
|||
EP-1778 | Combined intracavitary-interstitial IGABT of cervical cancer First dosimetric experience in Hungary | Georgina Frhlich | ![]() |
![]() |
|||
EP-1779 | HIGH-DOSE RATE BRACHYTHERAPY FOR INOPERABLE ENDOMETRIAL CANCER: DEFINITIVE RESULTS | Lorena Draghini | ![]() |
![]() |
|||
EP-1780 | Postoperative endometrium: 68Gy EQD2(a/=3) at 2cc of vagina is related to G2 late toxicity. | Angeles Rovirosa | ![]() |
![]() |
|||
EP-1782 | Effect of the amount of bladder filling on normal tissue doses in 3D-HDR vaginal vault brachytherapy | Ilhami Er | ![]() |
![]() |
|||
EP-1783 | Acute toxicity with Xoft Axxent Electronic Brachytherapy (XB) in endometrial or cervical cancer | ANABELA MIRANDA BURGOS | ![]() |
![]() |
|||
EP-1784 | Needle use in cervical cancer brachytherapy using the Utrecht applicator: a single center experience | Milena Smolic | ![]() |
![]() |
|||
EP-1785 | USE OF RECTAL TUBE IN VAGINAL CUFF HDR- BRACHYTHERAPY: AN UNEXPECTED ADVANTAGE | Brigida Pappalardi | ![]() |
![]() |
|||
EP-1786 | Intraoperative Brachytherapy (HDR-IOBT) in advanced or recurrence gynecologic cancer.. | ELENA VILLAFRANCA | ![]() |
![]() |
|||
EP-1787 | Dosimetric Implications of the organs at risk in Vaginal Cuff Brachytherapy with ML Cylinder | NIcolae Dumitru | ![]() |
![]() |
|||
EP-1789 | Comparison between MRI based 3D IGABT planning versus standardised BT planning of cervical cancer | Malin Hedetoft | ![]() |
![]() |
|||
EP-1790 | A balloon applicator with adjustable catheters for image-guided endoluminal rectal brachytherapy | Martin Heilmann | ![]() |
![]() |
|||
EP-1792 | Nasal function after exclusive brachytherapy for primary SCCs of the nasal vestibulum | Francesco Bussu | ![]() |
![]() |
|||
EP-1793 | High-dose-rate brachytherapy for lip and oral cavity tumors | Carolina De la Pinta Alonso | ![]() |
![]() |
|||
EP-1794 | Intra-op check of ONCURA Rapid Strand (Model 7000) seeds radioactivity in LDR prostate brachytherapy | Vladimir Stserbakov | ![]() |
![]() |
|||
EP-1795 | A novel MRI markers system in applicator reconstruction for brachytherapy | Antonio Otal | ![]() |
![]() |
|||
EP-1796 | Dosimetric comparison between TG43/TG186 algorithms and manual/inverse optimization in brachytherapy | Thomas BRUN | ![]() |
![]() |
|||
EP-1797 | Dosimetric characterization of MOSFET detectors for Ir-192 and feasibility for in vivo dosimetry. | Rosa Fabregat Borrás | ![]() |
![]() |
|||
EP-1798 | Highly conformal external beam modalities vs. brachytherapy boost for rectal cancer patients | Slobodan Devic | ![]() |
![]() |
|||
EP-1799 | Feasibility study of in vivo dosimetry with optically stimulated dosimeters for 50kVp Papillon beam | Catherine DEJEAN | ![]() |
![]() |
|||
EP-1800 | Optical Fibre Luminescence Sensor for Real-time LDR Brachytherapy Dosimetry | Peter Woulfe | ![]() |
![]() |
|||
EP-1801 | HDR-PLESIOTHERAPY FOR THE TREATMENT OF EXTRAMAMMARY PAGETS DISEASE. A CASE REPORT. | Paqui Ropero Carmona | ![]() |
![]() |
|||
EP-1802 | The role of the high dose rate brachytherapy in the conservative treatment of esophageal cancer. | Alexsey Lozhkov | ![]() |
![]() |
|||
EP-1803 | Moderate dose-escalation with perioperative HDR brachytherapy in soft tissue sarcomas | Xin Chen | ![]() |
![]() |
|||
EP-1804 | Laparoscopic robot-assisted brachytherapy of muscle-invasive bladder cancer: clinical case report | Francisco Mascarenhas | ![]() |
![]() |
|||
EP-1805 | Interstitial and superficial brachytherapy for skin cancer | Serhii Brovchuk | ![]() |
![]() |
|||
EP-1806 | HDR brachytherapy for superficial non-melanoma skin cancers. | Carolina De la Pinta Alonso | ![]() |
![]() |
|||
EP-1807 | Reducing Heart Toxicity In Medulloblastoma Using Proton Therapy | Abdossalam Madkhali | ![]() |
![]() |
|||
EP-1808 | The response of human induced pluripotent stem cell- derived chondrocytes to ionizing radiation | Ewelina Augustyniak | ![]() |
![]() |
|||
EP-1809 | Effect of thalidomide on radiation-induced urinary bladder dysfunction | Jakob Kowaliuk | ![]() |
![]() |
|||
EP-1810 | Both location and complexity of DNA damage contribute to radiation induced senescence | Wang Jufang | ![]() |
![]() |
|||
EP-1811 | Aligning the chest with a couch improved reproducibility in radiotherapy for head and neck cancers | Keiichiro Koiwai | ![]() |
![]() |
|||
EP-1813 | The investigation of the immobilization devices and localization methods for brain cancer in P-SRS. | REN-DUEN LIN | ![]() |
![]() |
|||
EP-1814 | Is AIO belly board device advantageous in all irradiated rectal cancer patients? | Dominika Hempel | ![]() |
![]() |
|||
EP-1815 | Technical aspects and setup irradiation of rats using a clinical accelerator | Vincenzo Sacco | ![]() |
![]() |
|||
EP-1816 | Neck positioning reproducibility of different pillow types in head and neck cancer patients | Wan hsuan Yu | ![]() |
![]() |
|||
EP-1817 | Breast set-up: Assessing two immobilization systems | Valentina Lancellotta | ![]() |
![]() |
|||
EP-1818 | The rate of a doctors progress in a learning curve in delineation of hippocampus | Monika Konopka-Filippow | ![]() |
![]() |
|||
EP-1819 | EORTC RTT Delineation Project: improving volume definition of OAR within the EORTC Lungtech trial | Marjolein van Os | ![]() |
![]() |
|||
EP-1820 | RapidArc vs IMRT in adjuvant gastric cancer irradiation: any dosimetric advantage? | Karim Mashhour | ![]() |
![]() |
|||
EP-1822 | Monitoring of parotid gland changes in radiotherapy of NPC with parapharyngeal space involvement | Vincent Wu | ![]() |
![]() |
|||
EP-1823 | DVH- and NTCP-based dosimetric comparison of different margins for VMAT-IMRT of esophageal cancer | Stefan Mnch | ![]() |
![]() |
|||
EP-1824 | Elective breast RT including level I & II lymph nodes: A planning study with the humeral head as PRV | Jorien van der Leer | ![]() |
![]() |
|||
EP-1826 | Analysis of dose distribution with change of the air gap when proton therapy using line scanning | Se Kwang Seo | ![]() |
![]() |
|||
EP-1827 | Dosimetric comparison of 3D-CRT, IMRT and VMAT for bilateral breast irradiation | Hing Ming Hung | ![]() |
![]() |
|||
EP-1828 | Mean Dose in healthy lung for chest tumors treated with Stereotactic Body Radiation Therapy (SBRT) | JOSE LUIS MONROY ANTON | ![]() |
![]() |
|||
EP-1829 | Dose delivery accuracy in total body irradiation delivered with Step and Shoot IMRT | Tim Berlon | ![]() |
![]() |
|||
EP-1830 | Simple method on bladder filling simulation to improve the soft-tissue evaluation on CBCT | Kirsten Legaard Jakobsen | ![]() |
![]() |
|||
EP-1831 | Entropic Boltzmann closure for MRI-guided radiotherapy | Jonathan Page | ![]() |
![]() |
|||
EP-1832 | Selecting head and neck cancer patients for proton therapy: the influence of (different) dosimetric thresholds | Ingrid Kuijper | ![]() |
![]() |
|||
EP-1833 | Bowel doses in cervical cancer patients treated with a full bladder during radiotherapy. | annette schouboe | ![]() |
![]() |
|||
EP-1834 | Dose to internal mammary nodes compared to dose to heart and lung for breast cancer patients | Martin Berg | ![]() |
![]() |
|||
EP-1835 | Independent verification of treatment planning system calculations | Edyta Dabrowska | ![]() |
![]() |
|||
EP-1836 | Study of changes in bowel gas in pelvic radiotherapy | Ashley Horne | ![]() |
![]() |
|||
EP-1838 | First IGRT results for SBRT bone and lymph node oligometastases within the pelvic region. | Lisa Wiersema | ![]() |
![]() |
|||
EP-1839 | Towards planning organ at risk volumes for rectum and bladder using cone beam CT in prostate cancer. | Piet Dirix | ![]() |
![]() |
|||
EP-1840 | Verification of accurate movement of 6DoF Couch using Yonsei QA Set. | Dongmin Jung | ![]() |
![]() |
|||
EP-1841 | CASPIR Trial: Interim analysis of prostatic calculi as an alternative to fiducial markers for IGRT | Angela ONeill | ![]() |
![]() |
|||
EP-1842 | Comparison between infrared marker and surface imaging for DIBH of left-sided breast treatments | Amanda Moreira | ![]() |
![]() |
|||
EP-1843 | An audit evaluating the frequency of patient re-preparation after CBCT analysis in prostate IMRT | Karen Crowther | ![]() |
![]() |
|||
EP-1844 | Clinical introduction of simple adaptive radiotherapy for transitional cell bladder carcinoma | Nicole Willems | ![]() |
![]() |
|||
EP-1845 | The impact of intra-fractional bladder filling on adaptive bladder radiotherapy | Aisling Krishnan | ![]() |
![]() |
|||
EP-1846 | Verification of Latency in Respiratory Gating with Proton Beam Therapy | isamu maeshima | ![]() |
![]() |
|||
EP-1847 | Inter-fraction motion of the uterine cervix during EBRT measured using CBCT and polymer markers | Ruud van Leeuwen | ![]() |
![]() |
|||
EP-1848 | Dosimetric evaluation of CBCT data in adaptive PoD for cervix cancer | Krupa Bath | ![]() |
![]() |
|||
EP-1849 | Implementation and verification of DIBH technique for treatment of left-sided breast cancer patients | Katarzyna Konat | ![]() |
![]() |
|||
EP-1850 | Effect of Meaning in Life on Smoking Behavior, Emotional Distress and Quality of Life in Male Head and Neck Cancer Survivors | Hsin-Yi Kuan | ![]() |
![]() |
|||
EP-1851 | Why is planned palliative radiotherapy often cancelled? A retrospective exploratory study | Helle Hansen | ![]() |
![]() |
|||
EP-1852 | A research interventional clinic within the NHS to enable participation in prostate clinical trials | Karen Crowther | ![]() |
![]() |
|||
EP-1854 | Information Seeking Patterns of Patients/Carers and Satisfaction with Web-based Resources | Agnella Craig | ![]() |
![]() |
|||
EP-1855 | Dedicated Patient Information Cancer Websites: A Usability Comparison | Sandra Wall | ![]() |
![]() |
|||
EP-1856 | The impact of waiting time on survival of Lung Stereotactic Ablative Body Radiotherapy patients | Yat Man Tsang | ![]() |
![]() |
|||
EP-1857 | Radiotherapy impairs on the bonding system in primary teeth | HARLEY FRANCISCO DE OLIVEIRA | ![]() |
![]() |
|||
EP-1858 | Implementation of nursing consultations following adjuvant radiotherapy for breast cancer | Suzanne Petri | ![]() |
![]() |
|||
EP-1859 | RTTs challenges in re-plan decision | Dariusz Rado&322;a | ![]() |
![]() |
|||
EP-1860 | A process and human factors engineering paradigm for radiation oncology | Kit Chi Chan | ![]() |
![]() |
|||
EP-1861 | Patient Satisfaction with Radiotherapy Services at Institute of Oncology in Ljubljana (Slovenia) | Valerija Zager Marcius | ![]() |
![]() |
|||
EP-1862 | Alert issues in the radiotherapy | Dénis Eijssen | ![]() |
![]() |
|||
EP-1863 | Risk analysis for image guided lung SBRT | Alberto Perez-Rozos | ![]() |
![]() |
|||
EP-1864 | Control of patients with pacemaker/implantable cardioverter defibrillator undergo radiotherapy. | MARIA DEL MAR PUERTAS | ![]() |
![]() |
|||
EP-1865 | The utilization of retrospective registry for patient information of access to care | Mervi Siekkinen | ![]() |
![]() |
5-9 May 2017 Vienna
![]() |
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|